Details of Drug

Drug General Information (ID: D0943)
Drug Name	Lomefloxacin
Drug Type	Small molecule
Drug Synonymous	LFLX; Lomefloxacine; Lomefloxacino; Lomefloxacinum; Lomefloxacine [French]; Lomefloxacino [Spanish]; Lomefloxacinum[Latin]; SC 4711; SC 47111A; DM 10 (bactericide); DM-10; Lomefloxacin (USAN); Maxaquin (TN); Maxaquin (hydrochloride); Okacyn (TN); SC-4711; SC-47111A; Uniquin (TN); Lomefloxacin [USAN:BAN:INN]; NY-198 (hydrochloride); SC-47111 (hydrochloride); SC-47111B (mesylate); (+-)-1-Ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1,4-Dihydro-6,8-difluoro-1-ethyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-Ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; 1-ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid; 3-Quinolinecarboxylic acid, 1-ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-, monohydrochloride Click to Show/Hide
Disease Class	1A00-1C4Z: Bacterial infection
Therapeutic Class	Antibiotics
Structure
Structure	3D Structure		2D Structure
Formula	C17H19F2N3O3
InChI	1S/C17H19F2N3O3/c1-3-21-8-11(17(24)25)16(23)10-6-12(18)15(13(19)14(10)21)22-5-4-20-9(2)7-22/h6,8-9,20H,3-5,7H2,1-2H3,(H,24,25)
InChIKey	ZEKZLJVOYLTDKK-UHFFFAOYSA-N
Canonical SMILES	CCN1C=C(C(=O)C2=CC(=C(C(=C21)F)N3CCNC(C3)C)F)C(=O)O
External Link
	Pubchem ID	3948
	CAS Number	98079-51-7
	CHEBI ID	116278
	TTD ID	D02KOF
	INTEDE ID	DR0968
	VARIDT ID	DR00507

Drug-Drug Interaction Network
Sunburst Graph		Legend Information AM001 Affected gastrointestinal absorption AM003 Affected organization distribution AM005 Affected excretion pathways AM006 Pharmacodynamic additive effects AM007 Pharmacodynamic antagonistic effects BM002 Altered intestinal flora BM003 Complex formation BM006 Altered intestinal mucosa BM014 Interference of cell/tissue uptake BM028 Competitive inhibition of renal tubular secretion BM029 Altered urine pH BM038 Additive CNS depression effects BM039 Additive CNS stimulant effects BM049 Increased risk of atrioventricular block BM050 Increased risk of bleeding BM064 Increased risk of hypoglycemia BM069 Increased risk of lowers seizure threshold BM074 Increased risk of peripheral neuropathy BM075 Increased risk of photosensitivity reactions BM076 Increased risk of prolong QT interval BM080 Increased risk of tendinitis/tendon rupture BM081 Increased risk of ventricular arrhythmias BM086 Antagonize the effect of antidiabetic agents BM089 Antagonize the effect of antihypertensive agents BM100 Antagonize the effect of vaccine/toxoid BM107 Attenuated pharmacological effects (Unspecific)
Relation Graph

Full list of drugs interacting with Lomefloxacin
Affected gastrointestinal absorption
	Altered intestinal flora					Drug Num: 2
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1095		Mycophenolic acid	C17H20O6	446541	Moderate		Inter Info	[319], [320]
D1094		Mycophenolate mofetil	C23H31NO7	5281078	Moderate		Inter Info	[319], [320]
	Complex formation					Drug Num: 31
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0235		Calcium acetate	C4H6CaO4	6116	Moderate		Inter Info	[188], [189], [190], [191], [192], [193], [194], [195], [196], [197], [198], [199], [200], [201], [202], [203], [204], [8], [60], [10], [205], [206], [207], [65], [208], [209], [210], [211], [212], [213], [214], [215]
D0483		Didanosine	C10H12N4O3	135398739	Moderate		Inter Info	[225], [226], [227], [228], [229], [230], [231], [232], [209], [233]
D0619		Ethinylestradiol	C20H24O2	5991	Moderate		Inter Info	[238], [239], [240]
D0049		Aluminum hydroxide	AlH3O3	10176082	Moderate		Inter Info	[188], [189], [190], [191], [192], [193], [194], [195], [196], [197], [198], [199], [200], [201], [202], [203], [204], [8], [60], [10], [205], [206], [207], [65], [208], [209], [210], [211], [212], [213], [214], [215]
D0236		Calcium carbonate	CCaO3	10112	Moderate		Inter Info	[201], [202], [211]
D0238		Calcium citrate	C12H10Ca3O14	13136	Moderate		Inter Info	[188], [189], [190], [191], [192], [193], [194], [195], [196], [197], [198], [199], [200], [201], [202], [203], [204], [8], [60], [10], [205], [206], [207], [65], [208], [209], [210], [211], [212], [213], [214], [215]
D0239		Calcium glubionate anhydrous	C18H32CaO19	64776	Moderate		Inter Info	[201], [202], [211]
D0241		Calcium gluconate	C12H22CaO14	9290	Moderate		Inter Info	[188], [189], [190], [191], [192], [193], [194], [195], [196], [197], [198], [199], [200], [201], [202], [203], [204], [8], [60], [10], [205], [206], [207], [65], [208], [209], [210], [211], [212], [213], [214], [215]
D0243		Calcium lactate	C6H10CaO6	13144	Moderate		Inter Info	[188], [189], [190], [191], [192], [193], [194], [195], [196], [197], [198], [199], [200], [201], [202], [203], [204], [8], [60], [10], [205], [206], [207], [65], [208], [209], [210], [211], [212], [213], [214], [215]
D0244		Calcium Phosphate	Ca3O8P2	24456	Moderate		Inter Info	[201], [202], [211]
D0649		Ferrous fumarate	C4H2FeO4	6433164	Moderate		Inter Info	[188], [189], [190], [191], [192], [193], [194], [195], [196], [197], [198], [199], [200], [201], [202], [203], [204], [8], [60], [10], [205], [206], [207], [65], [208], [209], [210], [211], [212], [213], [214], [215]
D0650		Ferrous gluconate	C12H22FeO14	23616740	Moderate		Inter Info	[188], [189], [190], [191], [192], [193], [194], [195], [196], [197], [198], [199], [200], [201], [202], [203], [204], [8], [60], [10], [205], [206], [207], [65], [208], [209], [210], [211], [212], [213], [214], [215]
D0651		Ferrous sulfate anhydrous	FeO4S	24393	Moderate		Inter Info	[201], [202], [211]
D0847		Iron	Fe	23925	Moderate		Inter Info	[201], [202], [211]
D0877		Kaolin	Al2H4O9Si2	56841936	Moderate		Inter Info	[201], [202], [211]
D0893		Lanthanum carbonate	C3La2O9	168924	Moderate		Inter Info	[1], [2], [3], [314], [315], [316]
D0968		Magnesium carbonate	CMgO3	11029	Moderate		Inter Info	[201], [202], [211]
D0969		Magnesium chloride	Cl2H12MgO6	643991	Moderate		Inter Info	[188], [189], [190], [191], [192], [193], [194], [195], [196], [197], [198], [199], [200], [201], [202], [203], [204], [8], [60], [10], [205], [206], [207], [65], [208], [209], [210], [211], [212], [213], [214], [215]
D0970		Magnesium citrate	C12H10Mg3O14	6099959	Moderate		Inter Info	[188], [189], [190], [191], [192], [193], [194], [195], [196], [197], [198], [199], [200], [201], [202], [203], [204], [8], [60], [10], [205], [206], [207], [65], [208], [209], [210], [211], [212], [213], [214], [215]
D0971		Magnesium gluconate	C12H22MgO14	11418570	Moderate		Inter Info	[188], [189], [190], [191], [192], [193], [194], [195], [196], [197], [198], [199], [200], [201], [202], [203], [204], [8], [60], [10], [205], [206], [207], [65], [208], [209], [210], [211], [212], [213], [214], [215]
D0973		Magnesium hydroxide	H2MgO2	14791	Moderate		Inter Info	[188], [189], [190], [191], [192], [193], [194], [195], [196], [197], [198], [199], [200], [201], [202], [203], [204], [8], [60], [10], [205], [206], [207], [65], [208], [209], [210], [211], [212], [213], [214], [215]
D0974		Magnesium oxide	MgO	14792	Moderate		Inter Info	[188], [189], [190], [191], [192], [193], [194], [195], [196], [197], [198], [199], [200], [201], [202], [203], [204], [8], [60], [10], [205], [206], [207], [65], [208], [209], [210], [211], [212], [213], [214], [215]
D1011		Mestranol	C21H26O2	6291	Moderate		Inter Info	[238], [239], [240]
D1456		Selenium	Se	6326970	Moderate		Inter Info	[188], [189], [190], [191], [192], [193], [194], [195], [196], [197], [198], [199], [200], [201], [202], [203], [204], [8], [60], [10], [205], [206], [207], [65], [208], [209], [210], [211], [212], [213], [214], [215]
D1566		Tetraferric tricitrate decahydrate	C18H32Fe4O31	90478690	Moderate		Inter Info	[201], [202], [211]
D1722		Zinc acetate	C4H6O4Zn	11192	Moderate		Inter Info	[188], [189], [190], [191], [192], [193], [194], [195], [196], [197], [198], [199], [200], [201], [202], [203], [204], [8], [60], [10], [205], [206], [207], [65], [208], [209], [210], [211], [212], [213], [214], [215]
D1724		Zinc gluconate	C12H22O14Zn	443445	Moderate		Inter Info	[188], [189], [190], [191], [192], [193], [194], [195], [196], [197], [198], [199], [200], [201], [202], [203], [204], [8], [60], [10], [205], [206], [207], [65], [208], [209], [210], [211], [212], [213], [214], [215]
D1725		Zinc sulfate	O4SZn	24424	Moderate		Inter Info	[188], [189], [190], [191], [192], [193], [194], [195], [196], [197], [198], [199], [200], [201], [202], [203], [204], [8], [60], [10], [205], [206], [207], [65], [208], [209], [210], [211], [212], [213], [214], [215]
D0975		Magnesium sulfate	MgO4S	24083	Moderate		Inter Info	[188], [189], [190], [191], [192], [193], [194], [195], [196], [197], [198], [199], [200], [201], [202], [203], [204], [8], [60], [10], [205], [206], [207], [65], [208], [209], [210], [211], [212], [213], [214], [215]
D1462		Sevelamer	C6H12ClNO	3085017	Moderate		Inter Info	[362]
D1511		Sucralfate	C12H54Al9O55S8	121494085	Moderate		Inter Info	[188], [189], [190], [191], [192], [193], [194], [195], [196], [197], [198], [199], [200], [201], [202], [203], [204], [8], [60], [10], [205], [206], [207], [65], [208], [209], [210], [211], [212], [213], [214], [215]
	Altered intestinal mucosa					Drug Num: 52
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0030		Aldesleukin	NA	NA	Minor		Inter Info	[337]
D0048		Altretamine	C9H18N6	2123	Minor		Inter Info	[337]
D0190		Bleomycin	C55H84N17O21S3+	5360373	Minor		Inter Info	[337]
D0260		Carboplatin	C6H12N2O4Pt	426756	Minor		Inter Info	[337]
D0264		Carmustine	C5H9Cl2N3O2	2578	Minor		Inter Info	[337]
D0312		Chlorambucil	C14H19Cl2NO2	2708	Minor		Inter Info	[337]
D0344		Cisplatin	Cl2H6N2Pt	5702198	Minor		Inter Info	[337]
D0357		Clofarabine	C10H11ClFN5O3	119182	Minor		Inter Info	[337]
D0400		Cyclophosphamide	C7H15Cl2N2O2P	2907	Minor		Inter Info	[337]
D0407		Dacarbazine	C6H10N6O	135398738	Minor		Inter Info	[337]
D0410		Dactinomycin	C62H86N12O16	457193	Minor		Inter Info	[337]
D0429		Daunorubicin	C27H29NO10	30323	Minor		Inter Info	[337]
D0430		Daunorubicin (liposomal)	C27H29NO10	30323	Minor		Inter Info	[337]
D0442		Denileukin diftitox	NA	NA	Minor		Inter Info	[337]
D0584		Epirubicin	C27H29NO11	41867	Minor		Inter Info	[337]
D0627		Etoposide	C29H32O13	36462	Minor		Inter Info	[337]
D0666		Floxuridine	C9H11FN2O5	5790	Minor		Inter Info	[337]
D0675		Fluorouracil	C4H3FN2O2	3385	Minor		Inter Info	[337]
D0714		Gemcitabine	C9H11F2N3O4	60750	Minor		Inter Info	[337]
D0717		Gemtuzumab ozogamicin	NA	NA	Minor		Inter Info	[337]
D0845		Irinotecan	C33H38N4O6	60838	Minor		Inter Info	[337]
D0223		Busulfan	C6H14O6S2	2478	Minor		Inter Info	[337]
D0249		Capecitabine	C15H22FN3O6	60953	Minor		Inter Info	[337]
D0404		Cytarabine	C9H13N3O5	6253	Minor		Inter Info	[337]
D0511		Docetaxel	C43H53NO14	148124	Minor		Inter Info	[337]
D0528		Doxorubicin	C27H29NO11	31703	Minor		Inter Info	[337]
D0669		Fludarabine	C10H12FN5O4	657237	Minor		Inter Info	[337]
D0780		Hydroxyurea	CH4N2O2	3657	Minor		Inter Info	[337]
D0788		Idarubicin	C26H27NO9	42890	Minor		Inter Info	[337]
D0790		Ifosfamide	C7H15Cl2N2O2P	3690	Minor		Inter Info	[337]
D0945		Lomustine	C9H16ClN3O2	3950	Minor		Inter Info	[337]
D0962		Lurbinectedin	C41H44N4O10S	57327016	Minor		Inter Info	[337]
D0996		Melphalan	C13H18Cl2N2O2	460612	Minor		Inter Info	[337]
D1007		Mercaptopurine	C5H4N4S	667490	Minor		Inter Info	[337]
D1079		Mitoxantrone	C22H28N4O6	4212	Minor		Inter Info	[337]
D1212		Paclitaxel	C47H51NO14	36314	Minor		Inter Info	[337]
D1213		Paclitaxel (protein-bound)	C47H51NO14	36314	Minor		Inter Info	[337]
D1345		Procarbazine	C12H19N3O	4915	Minor		Inter Info	[337]
D1575		Thiotepa	C6H12N3PS	5453	Minor		Inter Info	[337]
D1610		Topotecan	C23H23N3O5	60700	Minor		Inter Info	[337]
D0986		Mechlorethamine	C5H11Cl2N	4033	Minor		Inter Info	[337]
D1077		Mitomycin	C15H18N4O5	5746	Minor		Inter Info	[337]
D1250		Pentostatin	C11H16N4O4	439693	Minor		Inter Info	[337]
D1508		Streptozocin	C8H15N3O7	29327	Minor		Inter Info	[337]
D1548		Temozolomide	C6H6N6O2	5394	Minor		Inter Info	[337]
D1551		Teniposide	C32H32O13S	452548	Minor		Inter Info	[337]
D1589		Tioguanine	C5H5N5S	2723601	Minor		Inter Info	[337]
D1626		Tretinoin	C20H28O2	444795	Minor		Inter Info	[337]
D1697		Vinblastine	C46H58N4O9	13342	Minor		Inter Info	[337]
D1698		Vincristine	C46H56N4O10	5978	Minor		Inter Info	[337]
D1699		Vincristine (liposome)	C46H56N4O10	5978	Minor		Inter Info	[337]
D1700		Vinorelbine	C45H54N4O8	5311497	Minor		Inter Info	[337]
Affected organization distribution
	Interference of cell/tissue uptake					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1817		Indium In-111 oxyquinoline	C27H18InN3O3	16685037	Moderate		Inter Info	[312]
Affected excretion pathways
	Competitive inhibition of renal tubular secretion					Drug Num: 8
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0576		Entecavir	C12H15N5O3	135398508	Moderate		Inter Info	[237]
D1025		Methotrexate	C20H22N8O5	126941	Moderate		Inter Info	[337], [338], [339]
D1241		Pemetrexed	C20H21N5O6	135410875	Moderate		Inter Info	[345]
D0217		Bumetanide	C17H20N2O5S	2471	Minor		Inter Info	[371]
D0613		Etacrynic acid	C13H12Cl2O4	3278	Minor		Inter Info	[371]
D0704		Furosemide	C12H11ClN2O5S	3440	Minor		Inter Info	[371]
D1341		Probenecid	C13H19NO4S	4911	Minor		Inter Info	[60], [372], [373]
D1611		Torasemide	C16H20N4O3S	41781	Minor		Inter Info	[371]
	Altered urine pH					Drug Num: 3
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1760		Citric acid	C6H8O7	311	Moderate		Inter Info	[295], [9]
D1319		Potassium citrate	C6H5K3O7	13344	Moderate		Inter Info	[295], [9]
D1483		Sodium citrate	C6H5Na3O7	6224	Moderate		Inter Info	[295], [9]
Pharmacodynamic additive effects
	Additive CNS depression effects					Drug Num: 12
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0298		Celecoxib	C17H14F3N3O2S	2662	Moderate		Inter Info	[60], [205], [9], [7], [61], [216], [177], [64], [217], [218], [219], [220], [221], [10]
D0476		Diclofenac	C14H11Cl2NO2	3033	Moderate		Inter Info	[60], [205], [9], [7], [61], [216], [177], [64], [217], [218], [219], [220], [221], [10]
D0489		Diflunisal	C13H8F2O3	3059	Moderate		Inter Info	[60], [205], [9], [7], [61], [216], [177], [64], [217], [218], [219], [220], [221], [10]
D0624		Etodolac	C17H21NO3	3308	Moderate		Inter Info	[60], [205], [9], [7], [61], [216], [177], [64], [217], [218], [219], [220], [221], [10]
D0645		Fenoprofen	C15H14O3	3342	Moderate		Inter Info	[60], [205], [9], [7], [61], [216], [177], [64], [217], [218], [219], [220], [221], [10]
D0680		Flurbiprofen	C15H13FO2	3394	Moderate		Inter Info	[60], [205], [9], [7], [61], [216], [177], [64], [217], [218], [219], [220], [221], [10]
D0800		Indomethacin	C19H16ClNO4	3715	Moderate		Inter Info	[60], [205], [9], [7], [61], [216], [177], [64], [217], [218], [219], [220], [221], [10]
D0882		Ketorolac	C15H13NO3	3826	Moderate		Inter Info	[60], [205], [9], [7], [61], [216], [177], [64], [217], [218], [219], [220], [221], [10]
D0452		Deutetrabenazine	C19H27NO3	73437646	Moderate		Inter Info	[297]
D0786		Ibuprofen	C13H18O2	3672	Moderate		Inter Info	[60], [205], [9], [7], [61], [216], [177], [64], [217], [218], [219], [220], [221], [10]
D0881		Ketoprofen	C16H14O3	3825	Moderate		Inter Info	[60], [205], [9], [7], [61], [216], [177], [64], [217], [218], [219], [220], [221], [10]
D1673		Valbenazine	C24H38N2O4	24795069	Moderate		Inter Info	[332]
	Additive CNS stimulant effects					Drug Num: 13
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0017		Acetylsalicylic acid	C9H8O4	2244	Moderate		Inter Info	[177], [7], [60]
D0331		Choline salicylate	C12H19NO4	54686350	Moderate		Inter Info	[177], [7], [60]
D1196		Oxaprozin	C18H15NO3	4614	Moderate		Inter Info	[60], [205], [9], [7], [61], [216], [177], [64], [217], [218], [219], [220], [221], [10]
D1272		Phenyl salicylate	C13H10O3	8361	Moderate		Inter Info	[177], [7], [60]
D1442		Salsalate	C14H10O5	5161	Moderate		Inter Info	[60], [205], [9], [7], [61], [216], [177], [64], [217], [218], [219], [220], [221], [10]
D0988		Meclofenamic acid	C14H11Cl2NO2	4037	Moderate		Inter Info	[177], [7], [60]
D0991		Mefenamic acid	C15H15NO2	4044	Moderate		Inter Info	[60], [205], [9], [7], [61], [216], [177], [64], [217], [218], [219], [220], [221], [10]
D0995		Meloxicam	C14H13N3O4S2	54677470	Moderate		Inter Info	[60], [205], [9], [7], [61], [216], [177], [64], [217], [218], [219], [220], [221], [10]
D1097		Nabumetone	C15H16O2	4409	Moderate		Inter Info	[60], [205], [9], [7], [61], [216], [177], [64], [217], [218], [219], [220], [221], [10]
D1109		Naproxen	C14H14O3	156391	Moderate		Inter Info	[60], [205], [9], [7], [61], [216], [177], [64], [217], [218], [219], [220], [221], [10]
D1300		Piroxicam	C15H13N3O4S	54676228	Moderate		Inter Info	[60], [205], [9], [7], [61], [216], [177], [64], [217], [218], [219], [220], [221], [10]
D1520		Sulindac	C20H17FO3S	1548887	Moderate		Inter Info	[60], [205], [9], [7], [61], [216], [177], [64], [217], [218], [219], [220], [221], [10]
D1606		Tolmetin	C15H15NO3	5509	Moderate		Inter Info	[60], [205], [9], [7], [61], [216], [177], [64], [217], [218], [219], [220], [221], [10]
	Increased risk of atrioventricular block					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0992		Mefloquine	C17H16F6N2O	4046	Moderate		Inter Info	[3], [335], [336]
	Increased risk of bleeding					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1711		Warfarin	C19H16O4	54678486	Major		Inter Info	[170], [171], [172]
	Increased risk of hypoglycemia					Drug Num: 16
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0009		Acarbose	C25H43NO18	41774	Moderate		Inter Info	[174], [175], [176]
D0029		Albiglutide	C148H224N40O45	145994868	Moderate		Inter Info	[174], [175], [176]
D0042		Alogliptin	C18H21N5O2	11450633	Moderate		Inter Info	[174], [175], [176]
D0245		Canagliflozin	C24H25FO5S	24812758	Moderate		Inter Info	[174], [175], [176]
D0418		Dapagliflozin	C21H25ClO6	9887712	Moderate		Inter Info	[174], [175], [176]
D0565		Empagliflozin	C23H27ClO7	11949646	Moderate		Inter Info	[174], [175], [176]
D0930		Linagliptin	C25H28N8O2	10096344	Moderate		Inter Info	[174], [175], [176]
D0936		Liraglutide	C172H265N43O51	16134956	Moderate		Inter Info	[174], [175], [176]
D0941		Lixisenatide	C215H347N61O65S	90472060	Moderate		Inter Info	[174], [175], [176]
D1294		Pioglitazone	C19H20N2O3S	4829	Moderate		Inter Info	[174], [175], [176]
D1326		Pramlintide	C171H267N51O53S2	70691388	Moderate		Inter Info	[174], [175], [176]
D1449		Saxagliptin	C18H25N3O2	11243969	Moderate		Inter Info	[174], [175], [176]
D1477		Sitagliptin	C16H15F6N5O	4369359	Moderate		Inter Info	[174], [175], [176]
D1015		Metformin	C4H11N5	4091	Moderate		Inter Info	[174], [175], [176]
D1064		Miglitol	C8H17NO5	441314	Moderate		Inter Info	[174], [175], [176]
D1429		Rosiglitazone	C18H19N3O3S	77999	Moderate		Inter Info	[174], [175], [176]
	Increased risk of lowers seizure threshold					Drug Num: 7
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0220		Bupropion	C13H18ClNO	444	Major		Inter Info	[91], [92], [1], [93], [94], [95], [96], [97], [98], [99], [100], [101], [102], [103], [104]
D0833		Iohexol	C19H26I3N3O9	3730	Major		Inter Info	[114], [115], [116], [117], [118]
D0834		Iopamidol	C17H22I3N3O8	65492	Major		Inter Info	[114], [115], [116], [117], [118]
D1616		Tramadol	C16H25NO2	33741	Major		Inter Info	[168], [103], [102], [169]
D0932		Lindane	C6H6Cl6	727	Moderate		Inter Info	[252], [253], [254]
D0054		Amifampridine	C5H7N3	5918	Moderate		Inter Info	[3], [125], [255]
D0722		Ginkgo biloba	NA	NA	Moderate		Inter Info	[303], [304], [305], [306], [307], [308], [309], [310]
	Increased risk of photosensitivity reactions					Drug Num: 5
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0063		Aminolevulinic acid (topical)	C5H9NO3	137	Moderate		Inter Info	[2], [3], [186]
D1033		Methyl aminolevulinate (topical)	C6H11NO3	157922	Moderate		Inter Info	[2], [3], [186]
D1028		Methoxsalen	C12H8O4	4114	Moderate		Inter Info	[2], [295], [340], [341], [342]
D1314		Porfimer sodium	C68H74N8O11	135577896	Moderate		Inter Info	[348], [3], [349]
D1691		Verteporfin	C82H84N8O16	11980904	Moderate		Inter Info	[3], [295], [340], [370]
	Increased risk of prolong QT interval					Drug Num: 152
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0084		Anagrelide	C10H7Cl2N3O	135409400	Major		Inter Info	[1], [2], [3], [4]
D0320		Chloroquine	C18H26ClN3	2719	Major		Inter Info	[12], [3], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30]
D0345		Citalopram	C20H21FN2O	2771	Major		Inter Info	[1], [2], [3], [33], [34], [35], [36]
D0370		Clozapine	C18H19ClN4	135398737	Major		Inter Info	[1], [2], [3], [37], [35]
D0508		Disopyramide	C21H29N3O	3114	Major		Inter Info	[38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [7], [60], [61], [10], [62], [63], [64], [65], [66], [67], [68], [69], [70], [71], [72]
D0513		Dofetilide	C19H27N3O5S2	71329	Major		Inter Info	[1], [2], [3], [73]
D0514		Dolasetron	C19H20N2O3	3033818	Major		Inter Info	[1], [2], [3], [74]
D0535		Droperidol	C22H22FN3O2	3168	Major		Inter Info	[1], [2], [3], [75], [76], [35]
D0554		Efavirenz	C14H9ClF3NO2	64139	Major		Inter Info	[77]
D0750		Haloperidol	C21H23ClFNO2	3559	Major		Inter Info	[1], [2], [3], [78], [79], [80], [81], [82], [83], [35]
D0787		Ibutilide	C20H36N2O3S	60753	Major		Inter Info	[1], [2], [3], [84]
D0066		Amiodarone	C25H29I2NO3	2157	Major		Inter Info	[38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [7], [60], [61], [10], [62], [63], [64], [65], [66], [67], [68], [69], [70], [71], [72]
D0067		Amisulpride	C17H27N3O4S	2159	Major		Inter Info	[85]
D0149		Bedaquiline	C32H31BrN2O2	5388906	Major		Inter Info	[88]
D0230		Cabozantinib	C28H24FN3O5	25102847	Major		Inter Info	[3], [105]
D0302		Ceritinib	C28H36ClN5O3S	57379345	Major		Inter Info	[1], [2], [3], [106]
D0393		Crizotinib	C21H22Cl2FN5O	11626560	Major		Inter Info	[107]
D0534		Dronedarone	C31H44N2O5S	208898	Major		Inter Info	[1], [2], [3], [108]
D0599		Escitalopram	C20H21FN2O	146570	Major		Inter Info	[1], [109], [2], [3], [110], [111], [35]
D0779		Hydroxychloroquine	C18H26ClN3O	3652	Major		Inter Info	[12], [3], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30]
D0791		Iloperidone	C24H27FN2O4	71360	Major		Inter Info	[1], [2], [3], [113], [35]
D0872		Ivosidenib	C28H22ClF3N6O3	71657455	Major		Inter Info	[121], [122]
D0899		Lefamulin	C28H45NO5S	25185057	Major		Inter Info	[121], [123], [124]
D0960		Lumefantrine	C30H32Cl3NO	6437380	Major		Inter Info	[2], [3], [125]
D0965		Macimorelin	C26H30N6O3	9804938	Major		Inter Info	[126]
D1190		Osimertinib	C28H33N7O2	71496458	Major		Inter Info	[127]
D1221		Panobinostat	C21H23N3O2	6918837	Major		Inter Info	[129]
D1223		Papaverine	C20H21NO4	4680	Major		Inter Info	[130], [131], [132], [133], [134], [135], [136], [137]
D1230		Pasireotide	C58H66N10O9	9941444	Major		Inter Info	[1], [2], [3], [138]
D1292		Pimozide	C28H29F2N3O	16362	Major		Inter Info	[3], [75], [139], [35]
D1343		Procainamide	C13H21N3O	4913	Major		Inter Info	[38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [7], [60], [61], [10], [62], [63], [64], [65], [66], [67], [68], [69], [70], [71], [72]
D1398		Ribociclib	C23H30N8O	44631912	Major		Inter Info	[1], [2], [3], [75], [47], [140], [141], [35]
D1444		Saquinavir	C38H50N6O5	441243	Major		Inter Info	[142], [143], [1], [2], [3], [144], [145]
D1459		Selpercatinib	C29H31N7O3	134436906	Major		Inter Info	[146], [124]
D1681		Vandetanib	C22H24BrFN4O2	3081361	Major		Inter Info	[1], [2], [3], [150]
D1687		Vemurafenib	C23H18ClF2N3O3S	42611257	Major		Inter Info	[1], [2], [3], [151]
D1010		Mesoridazine	C21H26N2OS2	4078	Major		Inter Info	[2], [3], [153]
D1017		Methadone	C21H27NO	4095	Major		Inter Info	[1], [2], [3], [154], [155], [156], [157], [158], [159], [160], [161], [162], [163], [35]
D1063		Mifepristone	C29H35NO2	55245	Major		Inter Info	[1], [2], [3], [164]
D1371		Quinidine	C20H24N2O2	441074	Major		Inter Info	[38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [7], [60], [61], [10], [62], [63], [64], [65], [66], [67], [68], [69], [70], [71], [72]
D1498		Sotalol	C12H20N2O3S	5253	Major		Inter Info	[38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [7], [60], [61], [10], [62], [63], [64], [65], [66], [67], [68], [69], [70], [71], [72]
D1574		Thioridazine	C21H26N2S2	5452	Major		Inter Info	[3], [165], [166]
D1612		Toremifene	C26H28ClNO	3005573	Major		Inter Info	[1], [2], [3], [167]
D1726		Ziprasidone	C21H21ClN4OS	60854	Major		Inter Info	[1], [2], [3], [75], [173], [35]
D0036		Alfuzosin	C19H27N5O4	2092	Moderate		Inter Info	[1], [2], [3], [185], [35]
D0068		Amitriptyline	C20H23N	2160	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D0072		Amoxapine	C17H16ClN3O	2170	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D0097		Apomorphine	C17H17NO2	6005	Moderate		Inter Info	[1], [2], [3], [187], [35]
D0119		Atomoxetine	C17H21NO	54841	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D0219		Buprenorphine	C29H41NO4	644073	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D0324		Chlorpromazine	C17H19ClN2S	2726	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D0341		Ciprofloxacin	C17H18FN3O3	2764	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D0358		Clofazimine	C27H22Cl2N4	2794	Moderate		Inter Info	[222], [223], [224]
D0467		Dextropropoxyphene	C22H29NO2	10100	Moderate		Inter Info	[47], [141], [35]
D0597		Erythromycin	C37H67NO13	12560	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D0636		Famotidine	C8H15N7O2S3	5702160	Moderate		Inter Info	[2], [3], [241]
D0667		Fluconazole	C13H12F2N6O	3365	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D0676		Fluoxetine	C17H18F3NO	3386	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D0678		Fluphenazine	C22H26F3N3OS	3372	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D0682		Flutamide	C11H11F3N2O3	3397	Moderate		Inter Info	[3], [242], [243], [244], [245], [246], [247], [248]
D0737		Goserelin	C59H84N18O14	5311128	Moderate		Inter Info	[3], [242], [243], [244], [245], [246], [247], [248]
D0738		Granisetron	C18H24N4O	5284566	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D0781		Hydroxyzine	C21H27ClN2O2	3658	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D0795		Imipramine	C19H24N2	3696	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D0908		Leuprolide	C59H84N16O12	657181	Moderate		Inter Info	[3], [242], [243], [244], [245], [246], [247], [248]
D0007		Abiraterone	C24H31NO	132971	Moderate		Inter Info	[3], [242], [243], [244], [245], [246], [247], [248]
D0095		Apalutamide	C21H15F4N5O2S	24872560	Moderate		Inter Info	[3], [242], [243], [244], [245], [246], [247], [248]
D0105		Aripiprazole	C23H27Cl2N3O2	60795	Moderate		Inter Info	[2], [3], [286], [287], [288], [289], [290], [291]
D0112		Asenapine	C17H16ClNO	3036780	Moderate		Inter Info	[1], [2], [3], [292], [35]
D0180		Bicalutamide	C18H14F4N2O4S	2375	Moderate		Inter Info	[3], [242], [243], [244], [245], [246], [247], [248]
D0195		Bosutinib	C26H29Cl2N5O3	5328940	Moderate		Inter Info	[3], [294]
D0336		Cilostazol	C20H27N5O2	2754	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D0361		Clomipramine	C19H23ClN2	2801	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D0428		Dasatinib	C22H26ClN7O2S	3062316	Moderate		Inter Info	[296]
D0437		Degarelix	C82H103ClN18O16	16136245	Moderate		Inter Info	[3], [242], [243], [244], [245], [246], [247], [248]
D0446		Desipramine	C18H22N2	2995	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D0525		Doxepin	C19H21NO	667477	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D0569		Encorafenib	C22H27ClFN7O4S	50922675	Moderate		Inter Info	[298]
D0577		Entrectinib	C31H34F2N6O2	25141092	Moderate		Inter Info	[3], [299]
D0578		Enzalutamide	C21H16F4N4O2S	15951529	Moderate		Inter Info	[3], [242], [243], [244], [245], [246], [247], [248]
D0594		Eribulin	C40H59NO11	11354606	Moderate		Inter Info	[1], [2], [3], [300]
D0632		Ezogabine	C16H18FN3O2	121892	Moderate		Inter Info	[47], [141], [35]
D0664		Flecainide	C17H20F6N2O3	3356	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D0700		Fostemsavir	C25H26N7O8P	11319217	Moderate		Inter Info	[301]
D0720		Gilteritinib	C29H44N8O3	49803313	Moderate		Inter Info	[302]
D0725		Glasdegib	C21H22N6O	25166913	Moderate		Inter Info	[311]
D0751		Halothane	C2HBrClF3	3562	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D0758		Histrelin	C66H86N18O12	25077993	Moderate		Inter Info	[3], [242], [243], [244], [245], [246], [247], [248]
D0806		Inotuzumab ozogamicin	NA	NA	Moderate		Inter Info	[3], [313]
D0880		Ketoconazole	C26H28Cl2N4O4	456201	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D0894		Lapatinib	C29H26ClFN4O4S	208908	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D0903		Lenvatinib	C21H19ClN4O4	9823820	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D0937		Lisdexamfetamine	C15H25N3O	11597698	Moderate		Inter Info	[3]
D0940		Lithium carbonate	CLi2O3	11125	Moderate		Inter Info	[47], [141], [35]
D0942		Lofexidine	C11H12Cl2N2O	30668	Moderate		Inter Info	[1], [2], [3], [317], [35]
D0948		Lopinavir	C37H48N4O5	92727	Moderate		Inter Info	[1], [2], [318]
D1062		Midostaurin	C35H30N4O4	9829523	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D1169		Oliceridine	C22H30N2O2S	66553195	Moderate		Inter Info	[47], [141], [35]
D1189		Osilodrostat	C13H10FN3	44139752	Moderate		Inter Info	[121], [321], [124]
D1215		Paliperidone	C23H27FN4O3	115237	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D1232		Pazopanib	C21H23N7O2S	10113978	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D1290		Pimavanserin	C25H34FN3O2	10071196	Moderate		Inter Info	[322]
D1302		Pitolisant	C17H26ClNO	9948102	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D1315		Posaconazole	C37H42F2N8O4	468595	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D1339		Primaquine	C15H21N3O	4908	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D1352		Promethazine	C17H20N2S	4927	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D1353		Propafenone	C21H27NO3	4932	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D1368		Quetiapine	C21H25N3O2S	5002	Moderate		Inter Info	[1], [2], [3], [75], [324], [325], [326], [327], [35]
D1404		Rilpivirine	C22H18N6	6451164	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D1424		Romidepsin	C24H36N4O6S2	5352062	Moderate		Inter Info	[47], [141], [35]
D1432		Rucaparib	C19H18FN3O	9931954	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D1461		Sertraline	C17H17Cl2N	68617	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D1463		Sevoflurane	C4H3F7O	5206	Moderate		Inter Info	[1], [2], [3], [328]
D1491		Solifenacin	C23H26N2O2	154059	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D1522		Sunitinib	C22H27FN4O2	5329102	Moderate		Inter Info	[1], [2], [3], [329]
D1542		Telavancin	C80H106Cl2N11O27P	3081362	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D1560		Tetrabenazine	C19H27NO3	6018	Moderate		Inter Info	[1], [2], [3], [330], [35]
D1634		Triclabendazole	C14H9Cl3N2OS	50248	Moderate		Inter Info	[47], [141], [35]
D1651		Triptorelin	C64H82N18O13	25074470	Moderate		Inter Info	[3], [242], [243], [244], [245], [246], [247], [248]
D0947		Loperamide	C29H33ClN2O2	3955	Moderate		Inter Info	[333], [334]
D0979		Maprotiline	C20H23N	4011	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D1075		Mirtazapine	C17H19N3	4205	Moderate		Inter Info	[343]
D1137		Nilutamide	C12H10F3N3O4	4493	Moderate		Inter Info	[3], [242], [243], [244], [245], [246], [247], [248]
D1158		Nortriptyline	C19H21N	4543	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D1166		Olanzapine	C17H20N4S	135398745	Moderate		Inter Info	[2], [3], [344]
D1181		Ondansetron	C18H19N3O	4595	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D1193		Oxaliplatin	C8H14N2O4Pt	9887053	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D1210		Oxytocin	C43H66N12O12S2	439302	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D1216		Palonosetron	C19H24N2O	6337614	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D1246		Pentamidine	C19H24N4O2	4735	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D1254		Perflutren	C3F8	6432	Moderate		Inter Info	[346], [347]
D1257		Perphenazine	C21H26ClN3OS	4748	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D1346		Prochlorperazine	C20H24ClN3S	4917	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D1356		Propofol	C12H18O	4943	Moderate		Inter Info	[350], [351], [352], [353], [354], [355], [356], [357], [358], [359]
D1361		Protriptyline	C19H21N	4976	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D1372		Quinine	C20H24N2O2	3034034	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D1383		Ranolazine	C24H33N3O4	56959	Moderate		Inter Info	[360], [361]
D1413		Risperidone	C23H27FN4O2	5073	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D1497		Sorafenib	C21H16ClF3N4O3	216239	Moderate		Inter Info	[1], [2], [3], [363]
D1526		Tacrolimus	C44H69NO12	445643	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D1533		Tamoxifen	C26H29NO	2733526	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D1544		Telithromycin	C43H65N5O10	3002190	Moderate		Inter Info	[1], [3], [364]
D1596		Tizanidine	C9H8ClN5S	5487	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D1624		Trazodone	C19H22ClN5O	5533	Moderate		Inter Info	[365], [366], [286], [367], [368], [369], [35]
D1637		Trifluoperazine	C21H24F3N3S	5566	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D1647		Trimipramine	C20H26N2	5584	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D1682		Vardenafil	C23H32N6O4S	135400189	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D1683		Vasopressin	C46H65N15O12S2	644077	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D1689		Venlafaxine	C17H27NO2	5656	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D1706		Voriconazole	C16H14F3N5O	71616	Moderate		Inter Info	[1], [2], [3], [75], [47], [141], [35]
D1516		Sulfamethoxazole	C10H11N3O3S	5329	Minor		Inter Info	[1], [2], [374]
D1051		Metronidazole	C6H9N3O3	4173	Minor		Inter Info	[2], [375], [376], [377]
	Increased risk of tendinitis/tendon rupture					Drug Num: 10
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0172		Betamethasone	C22H29FO5	9782	Major		Inter Info	[5], [6], [7], [8], [9], [10], [11]
D0671		Fludrocortisone	C21H29FO5	31378	Major		Inter Info	[5], [6], [7], [8], [9], [10], [11]
D0773		Hydrocortisone	C21H30O5	5754	Major		Inter Info	[5], [6], [7], [8], [9], [10], [11]
D0155		Bempedoic acid	C19H36O5	10472693	Major		Inter Info	[89], [90]
D0436		Deflazacort	C25H31NO6	189821	Major		Inter Info	[5], [6], [7], [8], [9], [10], [11]
D0453		Dexamethasone	C22H29FO5	5743	Major		Inter Info	[5], [6], [7], [8], [9], [10], [11]
D1041		Methylprednisolone	C22H30O5	6741	Major		Inter Info	[5], [6], [7], [8], [9], [10], [11]
D1332		Prednisolone	C21H28O5	5755	Major		Inter Info	[5], [6], [7], [8], [9], [10], [11]
D1334		Prednisone	C21H26O5	5865	Major		Inter Info	[5], [6], [7], [8], [9], [10], [11]
D1628		Triamcinolone	C21H27FO6	31307	Major		Inter Info	[5], [6], [7], [8], [9], [10], [11]
	Increased risk of ventricular arrhythmias					Drug Num: 31
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0107		Arsenic trioxide	As2O3	14888	Major		Inter Info	[86], [87]
D0661		Fingolimod	C19H33NO2	107970	Major		Inter Info	[1], [2], [3], [112], [36]
D0868		Ivabradine	C27H36N2O5	132999	Major		Inter Info	[3], [119], [120]
D1211		Ozanimod	C23H24N4O3	52938427	Major		Inter Info	[128]
D1474		Siponimod	C29H35F3N2O3	44599207	Major		Inter Info	[2], [147]
D0025		Adenosine	C10H13N5O4	60961	Moderate		Inter Info	[1], [178], [2], [3], [179], [180], [181], [182], [183], [184]
D0516		Donepezil	C24H29NO3	3152	Moderate		Inter Info	[1], [2], [3], [234], [235], [236]
D0707		Galantamine	C17H21NO3	9651	Moderate		Inter Info	[1], [2], [3], [234], [235], [236]
D0888		Lactulose	C12H22O11	11333	Moderate		Inter Info	[1], [2], [3], [249], [250], [251]
D0103		Arformoterol	C19H24N2O4	3083544	Moderate		Inter Info	[256], [257], [258], [259], [260], [261], [262], [263], [264], [265], [266], [267], [268], [269], [270], [271], [272], [273], [274], [275], [276], [277], [278], [279], [280], [281], [282], [283], [284], [285]
D0184		Bisacodyl	C22H19NO4	2391	Moderate		Inter Info	[1], [2], [3], [249], [250], [251]
D0269		Castor oil	C57H104O9	14030006	Moderate		Inter Info	[1], [2], [3], [249], [250], [251]
D0691		Formoterol	C19H24N2O4	3410	Moderate		Inter Info	[256], [257], [258], [259], [260], [261], [262], [263], [264], [265], [266], [267], [268], [269], [270], [271], [272], [273], [274], [275], [276], [277], [278], [279], [280], [281], [282], [283], [284], [285]
D0701		Frangula purshiana bark	NA	NA	Moderate		Inter Info	[2], [3], [251]
D0731		Glycerin	C3H8O3	753	Moderate		Inter Info	[1], [2], [3], [249], [250], [251]
D0797		Indacaterol	C24H28N2O3	6918554	Moderate		Inter Info	[256], [257], [258], [259], [260], [261], [262], [263], [264], [265], [266], [267], [268], [269], [270], [271], [272], [273], [274], [275], [276], [277], [278], [279], [280], [281], [282], [283], [284], [285]
D0859		Isoprenaline	C11H17NO3	3779	Moderate		Inter Info	[269], [279], [282]
D0887		Lactitol	C12H24O11	157355	Moderate		Inter Info	[2], [3], [251]
D0924		Levosalbutamol	C13H21NO3	123600	Moderate		Inter Info	[269], [279], [282]
D1069		Mineral oil	NA	NA	Moderate		Inter Info	[1], [2], [3], [249], [250], [251]
D1171		Olodaterol	C21H26N2O5	11504295	Moderate		Inter Info	[256], [257], [258], [259], [260], [261], [262], [263], [264], [265], [266], [267], [268], [269], [270], [271], [272], [273], [274], [275], [276], [277], [278], [279], [280], [281], [282], [283], [284], [285]
D1298		Pirbuterol	C12H20N2O3	4845	Moderate		Inter Info	[269], [279], [282]
D1308		Polyethylene glycol (3350 with electrolytes)	C2H6O2	174	Moderate		Inter Info	[1], [206], [323]
D1309		Polyethylene glycol (3350)	C2H6O2	174	Moderate		Inter Info	[2], [3], [251]
D1418		Rivastigmine	C14H22N2O2	77991	Moderate		Inter Info	[1], [2], [3], [234], [235], [236]
D1438		Salbutamol	C13H21NO3	2083	Moderate		Inter Info	[269], [279], [282]
D1569		Thalidomide	C13H10N2O4	5426	Moderate		Inter Info	[2], [3], [331]
D1695		Vilanterol	C24H33Cl2NO5	10184665	Moderate		Inter Info	[269], [279], [282]
D1185		Orciprenaline	C11H17NO3	4086	Moderate		Inter Info	[269], [279], [282]
D1440		Salmeterol	C25H37NO4	5152	Moderate		Inter Info	[256], [257], [258], [259], [260], [261], [262], [263], [264], [265], [266], [267], [268], [269], [270], [271], [272], [273], [274], [275], [276], [277], [278], [279], [280], [281], [282], [283], [284], [285]
D1554		Terbutaline	C12H19NO3	5403	Moderate		Inter Info	[256], [257], [258], [259], [260], [261], [262], [263], [264], [265], [266], [267], [268], [269], [270], [271], [272], [273], [274], [275], [276], [277], [278], [279], [280], [281], [282], [283], [284], [285]
Pharmacodynamic antagonistic effects
	Antagonize the effect of antidiabetic agents					Drug Num: 19
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0325		Chlorpropamide	C10H13ClN2O3S	2727	Major		Inter Info	[31], [9], [32]
D0727		Glimepiride	C24H34N4O5S	3476	Major		Inter Info	[31], [9], [32]
D0811		Insulin glargine	C267H404N72O78S6	118984454	Major		Inter Info	[31], [9], [32]
D0814		Insulin human (inhalation, rapid acting)	C257H383N65O77S6	118984375	Major		Inter Info	[31], [9], [32]
D0815		Insulin human (isophane)	C257H383N65O77S6	118984375	Major		Inter Info	[31], [9], [32]
D0816		Insulin human (regular)	C257H383N65O77S6	118984375	Major		Inter Info	[31], [9], [32]
D0817		Insulin human (zinc extended)	C257H383N65O77S6	118984375	Major		Inter Info	[31], [9], [32]
D0818		Insulin human (zinc)	C257H383N65O77S6	118984375	Major		Inter Info	[31], [9], [32]
D0819		Insulin lispro	C257H389N65O77S6	16132438	Major		Inter Info	[31], [9], [32]
D0728		Glipizide	C21H27N5O4S	3478	Major		Inter Info	[31], [9], [32]
D0730		Glyburide	C23H28ClN3O5S	3488	Major		Inter Info	[31], [9], [32]
D0808		Insulin aspart (aspart)	C256H381N65O79S6	118984445	Major		Inter Info	[31], [9], [32]
D0809		Insulin degludec	C274H411N65O81S6	118984462	Major		Inter Info	[31], [9], [32]
D0810		Insulin detemir	C267H402N64O76S6	16137271	Major		Inter Info	[31], [9], [32]
D0812		Insulin glulisine	C258H384N64O78S6	16136701	Major		Inter Info	[31], [9], [32]
D1603		Tolbutamide	C12H18N2O3S	5505	Major		Inter Info	[31], [9], [32]
D1112		Nateglinide	C19H27NO3	5311309	Major		Inter Info	[31], [9], [32]
D1392		Repaglinide	C27H36N2O4	65981	Major		Inter Info	[31], [9], [32]
D1601		Tolazamide	C14H21N3O3S	5503	Major		Inter Info	[31], [9], [32]
	Antagonize the effect of antihypertensive agents					Drug Num: 4
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1779		Dulaglutide	NA	NA	Moderate		Inter Info	[174], [175], [176]
D1782		Ertugliflozin	C22H25ClO7	44814423	Moderate		Inter Info	[174], [175], [176]
D1784		Exenatide	C184H282N50O60S	45588096	Moderate		Inter Info	[174], [175], [176]
D1887		Semaglutide	C187H291N45O59	56843331	Moderate		Inter Info	[174], [175], [176]
	Antagonize the effect of vaccine/toxoid					Drug Num: 2
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1914		Typhoid vaccine (live)	NA	NA	Major		Inter Info	[3], [148], [149]
D1693		Vibrio cholerae CVD 103-HgR strain live antigen (live)	NA	NA	Major		Inter Info	[152]
	Attenuated pharmacological effects (Unspecific)					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0145		Balsalazide	C17H15N3O6	54585	Moderate		Inter Info	[293]

References
1	Canadian Pharmacists Association.
2	Cerner Multum, Inc. "Australian Product Information.".
3	Cerner Multum, Inc. "UK Summary of Product Characteristics.".
4	Product Information. Agrylin (anagrelide). Roberts Pharmaceutical Corporation, Eatontown, NJ.
5	FDA. U.S. Food and Drug Administration "Information for Healthcare Professionals. Fluoroquinolone Antimicrobial Drugs. FDA Alert [7/8/2008].".
6	Khaliq Y, Zhanel GG "Fluoroquinolone-Associated Tendinopathy: A Critical Review of the Literature." Clin Infect Dis 36 (2003): 1404-1410. [PMID: 12766835]
7	Product Information. Avelox (moxifloxacin) Bayer, West Haven, CT.
8	Product Information. Baxdela (delafloxacin). Melinta Therapeutics, Lincolnshire, IL.
9	Product Information. Cipro (ciprofloxacin). Bayer, West Haven, CT.
10	Product Information. Levaquin (levofloxacin). Ortho Pharmaceutical Corporation, Raritan, NJ.
11	van der Linden PD, Sturkenboom MC, Herings RM, Leufkens HM, Rowlands S, Stricker BH "Increased risk of achilles tendon rupture with quinolone antibacterial use, especially in elderly patients taking oral corticosteroids." Arch Intern Med 163 (2003): 1801-7. [PMID: 12912715]
12	Harper KM, Knapp DJ, Criswell HE, Breese GR "Vasopressin and alcohol: A multifaceted relationship." Psychopharmacology (Berl) 235 (2018): 3363-79. [PMID: 32936259]
13	Javelot H, El-Hage W, Meyer G, Becker G, Michel B, Hingray C "COVID-19 and (hydroxy)chloroquine-azithromycin combination: should we take the risk for our patients?" Br J Clin Pharmacol Apr 29 (2020): epub ahead of print. [PMID: 32350872]
14	National Institutes of Health (NIH) "Coronavirus Disease 2019 (COVID-19) Treatment Guidelines.".
15	Product Information. Chloroquine Phosphate (chloroquine). West-Ward Pharmaceutical Corporation, Eatontown, NJ.
16	Product Information. Hydroxychloroquine Sulfate (hydroxychloroquine). Prasco Laboratories, Cincinnati, OH.
17	Product Information. Plaquenil (R). (hydroxychloroquine). Sanofi Winthrop Pharmaceuticals, New York, NY.
18	Roden DM, Harrington RA, Poppas A, Russo AM "Considerations for drug interactions on QTc in exploratory COVID-19 (Coroanvirus disease 2019) treatment." Heart Rhythm Apr 14 (2020): epub ahead of print. [PMID: 32302703]
19	Sacher F, Fauchier L, Boveda S, et.al "Use of drugs with potential cardiac effect in the setting of SARS-CoV-2 infection." Arch Cardiovasc Dis Apr 24 (2020): epub ahead of print. [PMID: 32354666]
20	Saleh M, Gabriels J, ChangD, et.al "The effect of chloroquine, hydroxychloroquine and azithromycin on the corrected QT interval in patients with SARS-CoV-2 infection." Circ Arrhythm Electrophysiol Apr 29 (2020): epub ahead of print. [PMID: 32347743]
21	Sapp JL, Alqarawi W, MacIntyre CJ, et.al "Guidance on minimizing risk of drug-induced ventricular arrhythmia during treatment of COVID-19: A statement from the Canadian Heart Rhythm Society." Can J Cardiol Apr 8 (2020): epub ahead of print. [PMID: 32299753]
22	Smit C, Peeters MYM, van den Anker JN, Knibbe CAJ "Chloroquine for SARS-CoV-2: Implications of its unique pharmacokinetic and safety properties." Clin Pharmacokinet Ar 18 (2020): epub ahead of print. [PMID: 32306288]
23	Bessiere F, Roccia H, Deliniere A, et.al "Assessment of QT intervals in a case series of patients with coronavirus disease 2019 (COVID-19) infection treated with hydroxychloroquine alone or in combination with azithromycin in an intensive care unit." JAMA Cardiol May 1 (2020): epub ahead of print. [PMID: 32936266]
24	Borba MGS, Val FFA, Sampaio VS, et.al "Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 1 (SARS-CoV-2) infection: A randomized clinical trial." JAMA Netw Open Apr 1 (2020): epub ahead of print. [PMID: 32330277]
25	Giudicessi JR, Noseworthy PA, Friedman PA, Ackerman MJ "Urgent guidance for navigating and circumventing the QTc-prolonging and torsadogenic potential of possible pharmacotherapies for coronavirus disease 19 (COVID-19)" Mayo Clin Proc Apr 7 (2020): epub ahead of print. [PMID: 32359771]
26	Kapoor A, Pandurangi U, Arora V, et.al "Cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of COVID-19 patients: A scientific statement from the Indian Heart Rhythm Society." Indian Pacing Electorphysiol J Apr 8 (2020): epub ahead of print. [PMID: 32278018]
27	Mercuro NJ, Yen CF, Shim DJ, et.al "Risk of QT interval prolongation associated with the use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19)" JAMA Cardiol May 1:e201834 (2020): epub ahead of print. [PMID: 32936252]
28	mitra RL, Greenstein SA, Epstein lm "An algorithm for managing QT prolongation in coronavirus disease 2019 (COVID-19) patients treated with either chloroquine or hydroxychloroquine in conjunction with azithromycin Possible benefits of intravenous lidocaine." HeartRythm Case Rep Apr 1 (2020): epub ahead of print. [PMID: 32363145]
29	US Food and Drug Administration "FACT SHEET FOR HEALTH CARE PROVIDERS EMERGENCY USE AUTHORIZATION (EUA) OF CHLOROQUINE PHOSPHATE SUPPLIED FROM THE STRATEGIC NATIONAL STOCKPILE FOR TREATMENT OF COVID-19 IN CERTAIN HOSPITALIZED PATIENTS. Available from: URL: https://www.fda.gov/media/13653" ([2020, Apr 27]):.
30	US Food and Drug Administration "Hydroxychloroquine or Chloroquine for COVID-19: Drug Safety Communication - FDA Cautions Against Use Outside of the Hospital Setting or a Clinical Trial Due to Risk of Heart Rhythm Problems.".
31	Park-Wyllie LY, Juurlink DN, Kopp A, et al. "Outpatient gatifloxacin therapy and dysglycemia in older adults." N Engl J Med 354 (2006): 1352-61. [PMID: 16510739]
32	Saraya A, Yokokura M, Gonoi T, Seino S "Effects of fluoroquinolones on insulin secretion and beta-cell ATP-sensitive K(+) channels." Eur J Pharmacol 497 (2004): 111-7. [PMID: 15321742]
33	FDA. U.S. Food and Drug Administration "FDA Drug Safety Communication: Abnormal heart rhythms associated with high doses of Celexa (citalopram hydrobromide).".
34	Product Information. Celexa (citalopram). Forest Pharmaceuticals, St. Louis, MO.
35	EMA. European Medicines Agency. European Union "EMA - List of medicines under additional monitoring.".
36	FDA. U.S. Food and Drug Administration "FDA Drug Safety Communication: Revised recommendations for cardiovascular monitoring and use of multiple sclerosis drug Gilenya (fingolimod).".
37	Product Information. Clozaril (clozapine). Novartis Pharmaceuticals, East Hanover, NJ.
38	Ansari SR, Chopra N "Gatifloxacin and Prolonged QT Interval." Am J Med Sci 327 (2004): 55-6. [PMID: 14722399]
39	Ball P "Quinolone-induced QT interval prolongation: a not-so-unexpected class effect." J Antimicrob Chemother 45 (2000): 557-9. [PMID: 10797074]
40	Bertino JS Jr, Owens RC Jr, Carnes TD, Iannini PB "Gatifloxacin-associated corrected QT interval prolongation, torsades de pointes, and ventricular fibrillation in patients with known risk factors." Clin Infect Dis 34 (2002): 861-3. [PMID: 11830802]
41	Dale KM, Lertsburapa K, Kluger J, White CM "Moxifloxacin and torsade de pointes." Ann Pharmacother 41 (2007): 336-40. [PMID: 17284508]
42	Demolis JL, Charransol A, Funck-Brentano C, Jaillon P "Effects of a single oral dose of sparfloxacin on ventricular repolarization in healthy volunteers." Br J Clin Pharmacol 41 (1996): 499-503. [PMID: 8799513]
43	Demolis JL, Kubitza D, Tenneze L, Funck-Bretano C "Effect of a single oral dose of moxifloxacin (400 mg and 800 mg) on ventricular repolarization in healthy subjects." Clin Pharmacol Ther 68 (2000): 658-66. [PMID: 11180026]
44	Dupont H, Timsit JF, Souweine B, Gachot B, Wolff M, Regnier B "Torsades de pointe probably related to sparfloxacin." Eur J Clin Microbiol Infect Dis 15 (1996): 350-1. [PMID: 8781892]
45	Falagas ME, Rafailidis PI, Rosmarakis ES "Arrhythmias associated with fluoroquinolone therapy." Int J Antimicrob Agents 29 (2007): 374-9. [PMID: 17241772]
46	Frothingham R "Rates of torsades de pointes associated with ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin, and moxifloxacin." Pharmacotherapy 21 (2001): 1468-72. [PMID: 11765299]
47	Iannini PB "Cardiotoxicity of macrolides, ketolides and fluoroquinolones that prolong the QTc interval." Expert Opin Drug Saf 1 (2002): 121-8. [PMID: 12904146]
48	Iannini PB, Circiumaru I "Gatifloxacin-induced QTc prolongation and ventricular tachycardia." Pharmacotherapy 21 (2001): 361-2. [PMID: 11253862]
49	Iannini PB, Doddamani S, Byazrova E, Curciumaru I, Kramer H "Risk of torsades de pointes with non-cardiac drugs." BMJ 322 (2001): 46-7. [PMID: 11141163]
50	Jaillon P, Morganroth J, Brumpt I, Talbot G "Overview of electrocardiographic and cardiovascular safety data for sparfloxacin. Sparfloxacin Safety Group." J Antimicrob Chemother 37(suppl a) (1996): 161-7. [PMID: 8737135]
51	Kang J, Wang L, Chen XL, Triggle DJ, Rampe D "Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERG." Mol Pharmacol 59 (2001): 122-6. [PMID: 11125032]
52	Katritsis D, Camm AJ "Quinolones: cardioprotective or cardiotoxic." Pacing Clin Electrophysiol 26 (2003): 2317-20. [PMID: 14675020]
53	Lipsky BA, Dorr MB, Magner DJ, Talbot GH "Safety profile of sparfloxacin, a new fluoroquinolone antibiotic." Clin Ther 21 (1999): 148-59. [PMID: 10090432]
54	Makaryus AN, Byrns K, Makaryus MN, Natarajan U, Singer C, Goldner B "Effect of ciprofloxacin and levofloxacin on the QT interval: is this a significant "clinical" event?" South Med J 99 (2006): 52-6. [PMID: 16466123]
55	Noel GJ, Natarajan J, Chien S, Hunt TL, Goodman DB, Abels R "Effects of three fluoroquinolones on QT interval in healthy adults after single doses." Clin Pharmacol Ther 73 (2003): 292-303. [PMID: 12709719]
56	Oliphant CM, Green GM "Quinolones: a comprehensive review." Am Fam Physician 65 (2002): 455-64. [PMID: 11858629]
57	Owens RC "QT Prolongation with Antimicrobial Agents : Understanding the Significance." Drugs 64 (2004): 1091-124. [PMID: 15139788]
58	Owens RC "Risk assessment for antimicrobial agent-induced QTc interval prolongation and torsades de pointes." Pharmacotherapy 21 (2001): 301-19. [PMID: 11253855]
59	Owens RC Jr, Ambrose PG "Torsades de pointes associated with fluoroquinolones." Pharmacotherapy 22 (2002): 663-8 discussion 668-72. [PMID: 12013370]
60	Product Information. Factive (gemifloxacin). GeneSoft Inc, San Francisco, CA.
61	Product Information. Floxin (ofloxacin). Ortho Pharmaceutical Corporation, Raritan, NJ.
62	Product Information. Maxaquin (lomefloxacin). Searle, Skokie, IL.
63	Product Information. Noroxin (norfloxacin). Merck & Co, Inc, West Point, PA.
64	Product Information. Tequin (gatifloxacin) Bristol-Myers Squibb, Princeton, NJ.
65	Product Information. Zagam (sparfloxacin). Rhone-Poulenc Rorer, Collegeville, PA.
66	Samaha FF "QTC interval prolongation and polymorphic ventricular tachycardia in association with levofloxacin." Am J Med 107 (1999): 528-9. [PMID: 10569314]
67	Siepmann M, Kirch W "Drug points - Tachycardia associated with moxifloxacin." Br Med J 322 (2001): 23. [PMID: 11141146]
68	Stahlmann R "Clinical toxicological aspects of fluoroquinolones." Toxicol Lett 127 (2002): 269-77. [PMID: 12052667]
69	Thomas M, Maconochie JG, Fletcher E "The dilemma of the prolonged QT interval in early drug studies." Br J Clin Pharmacol 41 (1996): 77-81. [PMID: 8838432]
70	Tsikouris JP, Peeters MJ, Cox CD, Meyerrose GE, Seifert CF "Effects of three fluoroquinolones on QT analysis after standard treatment courses." Ann Noninvasive Electrocardiol 11 (2006): 52-6. [PMID: 16472283]
71	White CM, Grant EM, Quintiliani R "Moxifloxacin does increase the corrected QT interval." Clin Infect Dis 33 (2001): 1441-2. [PMID: 11565091]
72	Zix JA, GeerdesFenge HF, Rau M, Vockler J, Borner K, Koeppe P, Lode H "Pharmacokinetics of sparfloxacin and interaction with cisapride and sucralfate." Antimicrob Agents Chemother 41 (1997): 1668-72. [PMID: 9257738]
73	Product Information. Tikosyn (dofetilide) Pfizer US Pharmaceuticals, Atlanta, GA.
74	Product Information. Anzemet (dolasetron). Hoechst Marion-Roussel Inc, Kansas City, MO.
75	Glassman AH, Bigger JT Jr "Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death." Am J Psychiatry 158 (2001): 1774-82. [PMID: 11691681]
76	Product Information. Inapsine (droperidol). Janssen Pharmaceutica, Titusville, NJ.
77	Product Information. Sustiva (efavirenz). DuPont Pharmaceuticals, Wilmington, DE.
78	Hatta K, Takahashi T, Nakamura H, Yamashiro H, Asukai N, Matsuzaki I, Yonezawa Y "The association between intravenous haloperidol and prolonged QT interval." J Clin Psychopharmacol 21 (2001): 257-61. [PMID: 11386487]
79	Huyse F, van Schijndel RS "Haloperidol and cardiac arrest." Lancet 2 (1988): 568-9. [PMID: 2900948]
80	Metzger E, Friedman R "Prolongation of the corrected QT and torsades de pointes cardiac arrhythmia associated with intravenous haloperidol in the medically ill." J Clin Psychopharmacol 13 (1993): 128-32. [PMID: 8463445]
81	O'Brien JM, Rockwood RP, Suh KI "Haloperidol-induced torsade de pointes." Ann Pharmacother 33 (1999): 1046-9. [PMID: 10534216]
82	Product Information. Haldol (haloperidol). McNeil Pharmaceutical, Raritan, NJ.
83	Wilt JL, Minnema AM, Johnson RF, Rosenblum AM "Torsade de pointes associated with the use of intravenous haloperidol." Ann Intern Med 119 (1993): 391-4. [PMID: 8338292]
84	Product Information. Corvert (ibutilide). Pharmacia and Upjohn, Kalamazoo, MI.
85	Product Information. Barhemsys (amisulpride). Acacia Pharma, Inc, Indianapolis, IN.
86	Ohnishi K, Yoshida H, Shigeno K, et al. "Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia." Ann Intern Med 133 (2000): 881-5. [PMID: 11103058]
87	Product Information. Trisenox (arsenic trioxide) Cephalon Inc, West Chester, PA.
88	Product Information. Sirturo (bedaquiline). Janssen Pharmaceuticals, Titusville, NJ.
89	Product Information. Nexletol (bempedoic acid). Esperion Therapeutics, Ann Arbor, MI.
90	Product Information. Nexlizet (bempedoic acid-ezetimibe). Esperion Therapeutics, Ann Arbor, MI.
91	Product Information. Wellbutrin XL (buPROPion). GlaxoSmithKline, Philadelphia, PA.
92	Sheehan DV, Welch JB, Fishman SM "A case of bupropion-induced seizure." J Nerv Ment Dis 174 (1986): 496-8. [PMID: 3090199]
93	Product Information. Wellbutrin (bupropion). Glaxo Wellcome, Research Triangle Park, NC.
94	Gittelman DK, Kirby MG "A seizure following bupropion overdose." J Clin Psychiatry 54 (1993): 162. [PMID: 8486598]
95	Product Information. Wellbutrin SR (bupropion). Glaxo Wellcome, Research Triangle Park, NC.
96	James WA, Lippmann S "Bupropion: overview and prescribing guidelines in depression." South Med J 84 (1991): 222-4. [PMID: 1899294]
97	Masco HL, Kiev A, Holloman LC, Batey SR, Johnston JA, Lineberry CG "Safety and efficacy of bupropion and nortriptyline in outpatients with depression." Curr Ther Res Clin Exp 55 (1994): 851-63.
98	Dufresne RL, Weber SS, Becker RE "Bupropion hydrochloride." Drug Intell Clin Pharm 18 (1984): 957-64. [PMID: 6439541]
99	Product Information. Zyban (bupropion). Glaxo Wellcome, Research Triangle Park, NC.
100	Storrow AB "Bupropion overdose and seizure." Am J Emerg Med 12 (1994): 183-4. [PMID: 8161393]
101	Johnston JA, Lineberry CG, Ascher JA, et al. "A 102-center prospective study of seizure in association with bupropion." J Clin Psychiatry 52 (1991): 450-6. [PMID: 1744061]
102	Rosenstein DL, Nelson JC, Jacobs SC "Seizures associated with antidepressants: a review." J Clin Psychiatry 54 (1993): 289-99. [PMID: 8253696]
103	Pisani F, Spina E, Oteri G "Antidepressant drugs and seizure susceptibility: from in vitro data to clinical practice." Epilepsia 40(Suppl 10) (1999): S48-56. [PMID: 10609604]
104	Product Information. Aplenzin (buPROPion). sanofi-aventis , Bridgewater, NJ.
105	Product Information. Cometriq (cabozantinib). Exelixis Inc, S San Francisco, CA.
106	Product Information. Zykadia (ceritinib). Novartis Pharmaceuticals, East Hanover, NJ.
107	Product Information. Xalkori (crizotinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
108	Product Information. Multaq (dronedarone). sanofi-aventis , Bridgewater, NJ.
109	Castro VM, Clements CC, Murphy SN, et al. "QT interval and antidepressant use: a cross sectional study of electronic health records." BMJ 346 (2013): f288. [PMID: 23360890]
110	Do A, Noohi S, Elie D, et al. Health Canada Warning on Citalopram and Escitalopram--Its Effects on Prescribing in Consultation-Liaison Psychiatry.?Psychosomatics. 2016;57(1):57-63. [PMID: 26633294]
111	Product Information. Lexapro (escitalopram). Forest Pharmaceuticals, St. Louis, MO.
112	Product Information. Gilenya (fingolimod). Novartis Pharmaceuticals, East Hanover, NJ.
113	Product Information. Exforge HCT (amlodipine/hydrochlorothiazide/valsartan). Novartis Pharmaceuticals, East Hanover, NJ.
114	Product Information. Isovue-M-200 (iopamidol). Bracco Diagnostics Inc, Princeton, NJ.
115	Product Information. Amipaque (metrizamide) Nycomed Inc, Princeton, NJ.
116	Hindmarsh T, Grepe A, Widen L "Metrizamide-phenothiazine interaction: report of a case with seizures following myelography." Acta Radiol Diagn (Stockh) 16 (1975): 129-35. [PMID: 810000]
117	Product Information. Omnipaque 180 (iohexol). Amersham Health, Princeton, NJ.
118	Product Information. Osmovist 240 (iotrolan). Berlex Canada Inc, Lachine, QC.
119	Mittal SR "Slow junctional rhythm, QTc prolongation and transient torsades de-pointes following combined use of Ivabradine, Diltiazem and Ranolazine." J Assoc Physicians India 62 (2014): 426-7. [PMID: 25438492]
120	Product Information. Corlanor (ivabradine). Amgen USA, Thousand Oaks, CA.
121	Product Information. Fycompa (perampanel). Eisai Inc, Teaneck, NJ.
122	Product Information. Tibsovo (ivosidenib). Agios Pharmaceuticals, Cambridge, MA.
123	Product Information. Xenleta (lefamulin). Nabriva Therapeutics US, Inc., King of Prussia, PA.
124	Warrington SJ, Ankier SI, Turner P "Evaluation of possible interactions between ethanol and trazodone or amitriptyline." Neuropsychobiology 15 (1986): 31-7. [PMID: 3725002]
125	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
126	Product Information. Macrilen (macimorelin). Aeterna Zentaris, Charleston, SC.
127	Product Information. Tagrisso (osimertinib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
128	Product Information. Zeposia (ozanimod). Celgene Corporation, Summit, NJ.
129	Product Information. Farydak (panobinostat). Novartis Pharmaceuticals, East Hanover, NJ.
130	Goto M, Sato M, Kitzazawa H, et.al "Papaverine-induced QT interval prolongation and ventricular fibrillation in a patient with a history of drug-induced QT prolongation." Intern Med 53 (2014): 1629-31. [PMID: 25088875]
131	Inoue T, Asahi S, Takayanagi K, Morooka S, Takabatake Y "QT prolongation and possibility of ventricular arrhythmias after intracoronary papaverine." Cardiology 84 (1994): 9-13. [PMID: 7511988]
132	Jain A, Jenkins MG "Intracoronary electrocardiogram during torsade des pointes secondary to intracoronary papaverine." Cathet Cardiovasc Diagn 18 (1989): 255-7. [PMID: 2605630]
133	Kern MJ, Deligonul U, Serota H, Gudipati C, Buckingham T "Ventricular arrhythmia due to intracoronary papaverine: analysis of QT intervals and coronary vasodilatory reserve." Cathet Cardiovasc Diagn 19 (1990): 229-36. [PMID: 2334953]
134	Nakayama M, Saito A, Kitazawa H, et.al "Papaverine-induced polymorphic ventricular tachycardia in relation to QTU and giant T-U waves in four cases." Intern Med 51 (2012): 351-6. [PMID: 22333368]
135	Nakayama M, Tanaka N, Sakoda K, et.al "Papaverine-induced polymorphic ventricular tachycardia during coronary flow reserve study of patients with moderate coronary artery disease." Circ J 79 (2015): 530-6. [PMID: 25746536]
136	Talman CL, Winniford MD, Rossen JD, Simonetti I, Kienzle MG, Marcus ML "Polymorphous ventricular tachycardia: a side effect of intracoronary papaverine." J Am Coll Cardiol 15 (1990): 275-8. [PMID: 2299067]
137	Vrolix M, Piessens J, De Geest H "Torsades de pointes after intracoronary papaverine." Eur Heart J 12 (1991): 273-6. [PMID: 2044564]
138	Product Information. Signifor (pasireotide). Novartis Pharmaceuticals, East Hanover, NJ.
139	Product Information. Orap Tablets (pimozide). Gate Pharmaceuticals, Sellersville, PA.
140	Product Information. Kisqali (ribociclib). Novartis Pharmaceuticals, East Hanover, NJ.
141	Witchel HJ, Hancox JC, Nutt DJ "Psychotropic drugs, cardiac arrhythmia, and sudden death." J Clin Psychopharmacol 23 (2003): 58-77. [PMID: 12544377]
142	Anson BD, Weaver JG, Ackerman MJ, et al. "Blockade of HERG channels by HIV protease inhibitors." Lancet 365 (2005): 682-686. [PMID: 15721475]
143	Biondi L "Health Canada endorsed important safety information on Invirase (saquinavir mesylate)." .
144	Product Information. Invirase (saquinavir). Roche Laboratories, Nutley, NJ.
145	FDA. U.S. Food and Drug Administration "FDA drug safety communication: Ongoing safety review of Invirase (saquinavir) and possible association with abnormal heart rhythms.".
146	Product Information. Retevmo (selpercatinib). Lilly, Eli and Company, Indianapolis, IN.
147	Product Information. Mayzent (siponimod). Novartis Pharmaceuticals, East Hanover, NJ.
148	UK government "Typhoid.".
149	American Medical Association, Division of Drugs and Toxicology "Drug evaluations annual 1994." Chicago, IL: American Medical Association (1994).
150	Product Information. Vandetanib (vandetanib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
151	Product Information. Zelboraf (vemurafenib). Genentech, South San Francisco, CA.
152	Product Information. Vaxchora (cholera vaccine, live). PaxVax, Miami, FL.
153	Product Information. Serentil (mesoridazine) Boehringer-Ingelheim, Ridgefield, CT.
154	De Bels D, Staroukine M, Devriendt J "Torsades de pointes due to methadone." Ann Intern Med 139 (2003): E156. [PMID: 12859181]
155	Ehret GB, Desmeules JA, Broers B "Methadone-associated long QT syndrome: improving pharmacotherapy for dependence on illegal opioids and lessons learned for pharmacology." Expert Opin Drug Saf 6 (2007): 289-303. [PMID: 17480178]
156	Gil M, Sala M, Anguera I, et al. "QT prolongation and Torsades de Pointes in patients infected with human immunodeficiency virus and treated with methadone." Am J Cardiol 92 (2003): 995-7. [PMID: 14556883]
157	Krantz MJ, Kutinsky IB, Robertson AD, Mehler PS "Dose-related effects of methadone on QT prolongation in a series of patients with torsade de pointes." Pharmacotherapy 23 (2003): 802-5. [PMID: 12820821]
158	Krantz MJ, Lewkowiez L, Hays H, et al "Torsade de pointes associated with very-high-dose methadone." Ann Intern Med 137 (2002): 501-4. [PMID: 12230351]
159	Krantz MJ, Mehler PS "Synthetic opioids and QT prolongation." Arch Intern Med 163 (2003): 1615 author reply 1615. [PMID: 12860589]
160	Martell BA, Arnsten JH, Krantz MJ, Gourevitch MN "Impact of methadone treatment on cardiac repolarization and conduction in opioid users." Am J Cardiol 95 (2005): 915-8. [PMID: 15781034]
161	Mokwe EO, Ositadinma O "Torsade de pointes due to methadone." Ann Intern Med 139 (2003): W64. [PMID: 12966000]
162	Sala M, Anguera I, Cervantes M "Torsade de pointes due to methadone." Ann Intern Med 139 (2003): W64. [PMID: 12966001]
163	Walker PW, Klein D, Kasza L "High dose methadone and ventricular arrhythmias: a report of three cases." Pain 103 (2003): 321-4. [PMID: 12791438]
164	Product Information. Korlym (mifepristone). Corcept Therapeutics Incorporated, Menlo Park, CA.
165	Liberatore MA, Robinson DS "Torsade de pointes: a mechanism for sudden death associated with neuroleptic drug therapy?" J Clin Psychopharmacol 4 (1984): 143-6. [PMID: 6145728]
166	Product Information. Mellaril (thioridazine). Sandoz Pharmaceuticals Corporation, East Hanover, NJ.
167	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
168	Product Information. Ultram (tramadol). McNeil Pharmaceutical, Raritan, NJ.
169	Gardiner JS, Blough D, Drinkard CR, et al. "Tramadol and seizures: a surveillance study in a managed care population." Pharmacotherapy 20 (2000): 1423-31. [PMID: 11130214]
170	Arnold LM, Nissen LR, Ng TM "Moxifloxacin and warfarin: additional evidence for a clinically relevant interaction." Pharmacotherapy 25 (2005): 904-7.[PMID: 15927911]
171	Glasheen JJ, Fugit RV, Prochazka AV "Effect of levofloxacin coadministration on the international normalized ratios during warfarin therapy--a comment." Pharmacotherapy 23 (2003): 1079-80 discussion 1080.[PMID: 12921255]
172	Bianco TM, Bussey HI, Farnett LE, Linn WD, Roush MK, Wong YW "Potential warfarin-ciprofloxacin interaction in patients receiving long-term anticoagulation." Pharmacotherapy 12 (1992): 435-9.[PMID: 1492006]
173	Product Information. Geodon (ziprasidone). Pfizer US Pharmaceuticals, New York, NY.
174	Gavin JR 3rd, Kubin R, Choudhri S, et al "Moxifloxacin and glucose homeostasis: a pooled-analysis of the evidence from clinical and postmarketing studies." Drug Saf 27 (2004): 671-86. [PMID: 15230648]
175	Kelesidis T, Canseco E "Quinolone-induced hypoglycemia: a life-threatening but potentially reversible side effect." Am J Med 123 (2010): e5-6. [PMID: 20103009]
176	Yip C, Lee AJ "Gatifloxacin-induced hyperglycemia: a case report and summary of the current literature." Clin Ther 28 (2006): 1857-66. [PMID: 17213006]
177	Davey PG "Overview of drug interactions with the quinolones." J Antimicrob Chemother 22(suppl c) (1988): 97-107. [PMID: 3053579]
178	Celiker A, Tokel K, Cil E, Ozkutlu S, Ozme S "Adenosine induced torsades de pointes in a child with congenital long QT syndrome." Pacing Clin Electrophysiol 17 (1994): 1814-7. [PMID: 7838793]
179	Teodorovich N, Margolin E, Kogan Y, Paz O, Swissa M. Torsades de pointes after adenosine administration. J Electrocardiol. 2016;49(2):171-173. [PMID: 26850499]
180	Harrington GR, Froelich EG "Adenosine-induced torsades de pointes." Chest 103 (1993): 1299-1301. [PMID: 8131497]
181	Mallet ML "Proarrhythmic effects of adenosine: a review of the literature." Emerg Med J 21 (2004): 408-10. [PMID: 15208219]
182	Michalets EL, Williams CR "Drug interactions with cisapride: clinical implications." Clin Pharmacokinet 39 (2000): 49-75. [PMID: 10926350]
183	Tachakra SS, Robinson S "Adenosine and cardiac arrhythmias." BMJ 305 (1992): 422. [PMID: 1392935]
184	Wesley RC Jr, Turnquest P "Torsades de pointe after intravenous adenosine in the presence of prolonged QT syndrome." Am Heart J 123 (1992): 794-6. [PMID: 1539535]
185	Product Information. Uroxatral (alfuzosin). sanofi-aventis , Bridgewater, NJ.
186	Product Information. Metvixia (methyl aminolevulinate topical). Galderma Laboratories Inc, Cranbury, NJ.
187	Product Information. Apokyn (apomorphine). Mylan Pharmaceuticals Inc, Morgantown, WV.
188	Akerele JO, Okhamafe AO "Influence of oral co-administered metallic drugs on ofloxacin pharmacokinetics." J Antimicrob Chemother 28 (1991): 87-94. [PMID: 1663108]
189	Allen A, Vousden M, Porter A, Lewis A "Effect of Maalox((R)) on the bioavailability of oral gemifloxacin in healthy volunteers." Chemotherapy 45 (1999): 504-11. [PMID: 10567782]
190	Campbell NR, Kara M, Hasinoff BB, Haddara WM, McKay DW "Norfloxacin interaction with antacids and minerals." Br J Clin Pharmacol 33 (1992): 115-6. [PMID: 1540482]
191	Frost RW, Lasseter KC, Noe AJ, Shamblen EC, Lettieri JT "Effects of aluminum hydroxide and calcium carbonate antacids on the bioavailability of ciprofloxacin." Antimicrob Agents Chemother 36 (1992): 830-2. [PMID: 1503446]
192	Garrelts JC, Godley PJ, Peterie JD, Gerlach EH, Yakshe CC "Sucralfate significantly reduces ciprofloxacin concentrations in serum." Antimicrob Agents Chemother 34 (1990): 931-3. [PMID: 2360833]
193	Grasela TH Jr, Schentag JJ, Sedman AJ, et al "Inhibition of enoxacin absorption by antacids or ranitidine." Antimicrob Agents Chemother 33 (1989): 615-7. [PMID: 2751276]
194	Honig PK, Gillespie BK "Clinical significance of pharmacokinetic drug interactions with over-the-counter (OTC) drugs." Clin Pharmacokinet 35 (1998): 167-71. [PMID: 9784931]
195	Johnson RD, Dorr MB, Talbot GH, Caille G "Effect of Maalox on the oral absorption of sparfloxacin." Clin Ther 20 (1998): 1149-58. [PMID: 9916608]
196	Kamberi M, Nakashima H, Ogawa K, Oda N, Nakano S "The effect of staggered dosing of sucralfate on oral bioavailability of sparfloxacin." Br J Clin Pharmacol 49 (2000): 98-103. [PMID: 10671902]
197	Lehto P, Kivisto KT "Different effects of products containing metal ions on the absorption of lomefloxacin." Clin Pharmacol Ther 56 (1994): 477-82. [PMID: 7955811]
198	Lehto P, Kivisto KT "Effect of sucralfate on absorption of norfloxacin and ofloxacin." Antimicrob Agents Chemother 38 (1994): 248-51. [PMID: 8192452]
199	Lober S, Ziege S, Rau M, Schreiber G, Mignot A, Koeppe P, Lode H "Pharmacokinetics of gatifloxacin and interaction with an antacid containing aluminum and magnesium." Antimicrob Agents Chemother 43 (1999): 1067-71. [PMID: 10223915]
200	Nix DE, Watson WA, Lener ME, et al "Effects of aluminum and magnesium antacids and ranitidine on the absorption of ciprofloxacin." Clin Pharmacol Ther 46 (1989): 700-5. [PMID: 2598571]
201	Nix DE, Wilton JH, Ronald B, Distlerath L, Williams VC, Norman A "Inhibition of norfloxacin absorption by antacids." Antimicrob Agents Chemother 34 (1990): 432-5. [PMID: 2334155]
202	Noyes M, Polk RE "Norfloxacin and absorption of magnesium-aluminum." Ann Intern Med 109 (1988): 168-9. [PMID: 3382110]
203	Parpia SH, Nix DE, Hejmanowski LG, Goldstein HR, Wilton JH, Schentag JJ "Sucralfate reduces the gastrointestinal absorption of norfloxacin." Antimicrob Agents Chemother 33 (1989): 99-102. [PMID: 2712548]
204	Polk RE, Helay DP, Sahai J, Drwal L, Racht E "Effect of ferrous sulfate and multivitamins with zinc on absorption of ciprofloxacin in normal volunteers." Antimicrob Agents Chemother 33 (1989): 1841-4. [PMID: 2610494]
205	Product Information. Raxar (grepafloxacin). Glaxo Wellcome, Research Triangle Park, NC.
206	Product Information. Suprep Bowel Prep Kit (magnesium/potassium/sodium sulfates). Braintree Laboratories, Braintree, MA.
207	Product Information. Trovan (trovafloxacin). Pfizer US Pharmaceuticals, New York, NY.
208	Sahai J, Healy DP, Stotka J, Polk RE "The influence of chronic administration of calcium carbonate on the bioavailability of oral ciprofloxacin." Br J Clin Pharmacol 35 (1993): 302-4. [PMID: 8471407]
209	Shimada J, Shiba K, Oguma T, et al "Effect of antacid on absorption of the quinolone lomefloxacin." Antimicrob Agents Chemother 36 (1992): 1219-24. [PMID: 1329615]
210	Spivey JM, Cummings DM, Pierson NR "Failure of prostatitis treatment secondary to probable ciprofloxacin-sucralfate drug interaction." Pharmacotherapy 16 (1996): 314-6. [PMID: 8820479]
211	Teng R, Dogolo LC, Willavize SA, Friedman HL, Vincent J "Effect of Maalox and omeprazole on the bioavailability of trovafloxacin." J Antimicrob Chemother 39 Suppl B (1997): 93-7. [PMID: 9222077]
212	Wadworth AN, Goa KL "Lomefloxacin: a review of its antibacterial activity, pharmacokinetic properties and therapeutic use." Drugs 42 (1991): 1018-60. [PMID: 1724637]
213	Yuk JH "Ciprofloxacin levels when receiving sucralfate." J Am Geriatr Soc 262 (1989): 901. [PMID: 2754785]
214	Zix JA, Geerdes-Fenge HF, Rau M, Vockler J, Borner K, Koeppe P, Lode H "Pharmacokinetics of sparfloxacin and interaction with cisapride and sucralfate." Antimicrob Agents Chemother 41 (1997): 1668-72. [PMID: 9257738]
215	Deppermann KM, Lode H, Hoffken G, Tschink G, Kalz C, Koeppe P "Influence of ranitidine, pirenzepine, and aluminum magnesium hydroxide on the bioavailability of various antibiotics, including amoxicillin, cephalexin, doxycycline, and amoxicillin-clavulanic acid." Antimicrob Agents Chemother 33 (1989): 1901-7. [PMID: 2610502]
216	Product Information. Penetrex (enoxacin). Rhone-Poulenc Rorer, Collegeville, PA.
217	Ball P, Tillotson G "Tolerability of fluoroquinolone antibiotics: past, present and future." Drug Saf 13 (1996): 343-8. [PMID: 8652079]
218	Segev S. Rehavi M, Rubinstein E "Quinolones, theophylline, and diclofenac interactions with the gamma-aminobutyric acid receptor." Antimicrob Agents Chemother 32 (1988): 1624-6. [PMID: 2855295]
219	Domagala JM "Structure-activity and structure-side-effect relationships for the quinolone antibacterials." J Antimicrob Chemother 33 (1994): 685-706. [PMID: 8056688]
220	Hooper DC, Wolfson JS "The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans." Antimicrob Agents Chemother 28 (1985): 716-21. [PMID: 2936302]
221	Ball P "Ciprofloxacin: an overview of adverse experiences." J Antimicrob Chemother 18 (1986): 187-93. [PMID: 3542945]
222	Product Information. Lamprene (clofazimine). Novartis Pharmaceuticals, East Hanover, NJ.
223	Product Information. VFEND (voriconazole). Pfizer U.S. Pharmaceuticals, New York, NY.
224	Wohlt PD, Zheng L, Gunderson S, Balzar SA, Johnson BD, Fish JT "Recommendations for the use of medications with continuous enteral nutrition." Am J Health Syst Pharm 66 (2009): 1438-67. [PMID: 19667002]
225	Deppermann KM, Lode H "Fluoroquinolones: interaction profile during enteral absorption." Drugs 45 Suppl 3 (1993): 65-72. [PMID: 7689454]
226	Knupp CA, Barbhaiya RH "A multiple-dose pharmacokinetic interaction study between didanosine (videx(r)) and ciprofloxacin (cipro(r)) in male subjects seropositive for HIV but asymptomatic." Biopharm Drug Dispos 18 (1997): 65-77. [PMID: 9008270]
227	Marchbanks CR "Drug-drug interactions with fluoroquinolones." Pharmacotherapy 13 (1993): s23-8. [PMID: 8474934]
228	Mizuki Y, Fujiwara I, Yamaguchi T "Pharmacokinetic interactions related to the chemical structures of fluoroquinolones." J Antimicrob Chemother 37 Suppl A (1996): 41-55. [PMID: 8737124]
229	Polk RE "Drug-drug interactions with ciprofloxacin and other fluoroquinolones." Am J Med 87 (1989): s76-81. [PMID: 2686430]
230	Product Information. Videx (didanosine). Bristol-Myers Squibb, Princeton, NJ.
231	Sahai J, Gallicano K, Oliveras L, Khaliq S, Hawley-Foss N, Garber G "Cations in the didanosine tablet reduce ciprofloxacin bioavailability." Clin Pharmacol Ther 53 (1993): 292-7. [PMID: 8453847]
232	Shiba K, Sakamoto M, Nakazawa Y, Sakai O "Effects of antacid on absorption and excretion of new quinolones." Drugs 49(Suppl 2) (1995): 360-1. [PMID: 8549362]
233	Damle BD, Mummaneni V, Kaul S, Knupp C "Lack of Effect of Simultaneously Administered Didanosine Encapsulated Enteric Bead Formulation (Videx EC) on Oral Absorption of Indinavir, Ketoconazole, or Ciprofloxacin." Antimicrob Agents Chemother 46 (2002): 385-91. [PMID: 11796346]
234	Product Information. Aricept (donepezil). Pfizer US Pharmaceuticals, New York, NY.
235	Product Information. Exelon (rivastigmine) Novartis Pharmaceuticals, East Hanover, NJ.
236	Product Information. Razadyne (galantamine). Johnson and Johnson Medical Inc, Arlington, TX.
237	Product Information. Baraclude (entecavir). Bristol-Myers Squibb, Princeton, NJ.
238	Friedman CI, Huneke AL, Kim MH, Powell J "The effect of ampicillin on oral contraceptive effectiveness." Obstet Gynecol 55 (1980): 33-7. [PMID: 7188714]
239	Kleier DJ, Tucker JE "Oral contraceptive failure secondary to dentally prescribed drugs: fact or fiction?" J Colo Dent Assoc 66 (1987): 5-6. [PMID: 3478352]
240	Silber TJ "Apparent oral contraceptive failure associated with antibiotic administration." J Adolesc Health Care 4 (1983): 287-9. [PMID: 6643209]
241	Product Information. Pepcid (famotidine). Merck & Co, Inc, West Point, PA.
242	Product Information. Eligard (leuprolide). Sanofi Winthrop Pharmaceuticals, New York, NY.
243	Product Information. Firmagon (degarelix). Ferring Pharmaceuticals Inc, Tarrytown, NY.
244	Product Information. Lupron (leuprolide). TAP Pharmaceuticals Inc, Deerfield, IL.
245	Product Information. Plenaxis (abarelix). Praecis Pharmaceuticals Inc, Waltham, MA.
246	Product Information. Trelstar (triptorelin) Pharmacia and Upjohn, Kalamazoo, MI.
247	Product Information. Vantas (histrelin). Endo Pharmaceuticals (formally Indevus Pharmaceuticals Inc), Lexington, MA.
248	Product Information. Zoladex (goserelin). Zeneca Pharmaceuticals, Wilmington, DE.
249	Chin RL "Laxative-induced hypokalemia." Ann Emerg Med 32 (1998): 517-8. [PMID: 9774942]
250	Muller-Lissner SA "Adverse effects of laxatives: fact and fiction." Pharmacology 47 (1993): 138-45. [PMID: 8234421]
251	Schaefer DC, Cheskin LJ "Constipation in the elderly." Am Fam Physician 58 (1998): 907-14. [PMID: 9767726]
252	Matsuoka LY "Convulsions following application of gamma benzene hexachloride." J Am Acad Dermatol 5 (1981): 98-9. [PMID: 6168673]
253	Cox R, Krupnick J, Bush N, Houpt A "Seizures caused by concomitant use of lindane and dextroamphetamine in a child with attention deficit hyperactivity disorder." J Miss State Med Assoc 41 (2000): 690-2. [PMID: 10974795]
254	Product Information. Kwell (lindane). Reed and Carnrick, Jersey City, NJ.
255	Product Information. Firdapse (amifampridine). Catalyst Pharmaceuticals, Inc., Coral Gables, FL.
256	Bengtsson B, Fagerstrom PO "Extrapulmonary effects of terbutaline during prolonged administration." Clin Pharmacol Ther 31 (1982): 726-32. [PMID: 7042176]
257	Braden GL, vonOeyen PT, Germain MJ, Watson DJ, Haag BL "Ritodrine- and terbutaline-induced hypokalemia in preterm labor: Mechanisms and consequences." Kidney Int 51 (1997): 1867-75. [PMID: 9186877]
258	Clifton GD, Hunt BA, Patel RC, Burki NK "Effects of sequential doses of parenteral terbutaline on plasma levels of potassium and related cardiopulmonary responses." Am Rev Respir Dis 141 (1990): 575-9. [PMID: 2178522]
259	Dickens GR, Mccoy RA, West R, Stapczynski JS, Clifton GD "Effect of nebulized albuterol on serum potassium and cardiac rhythm in patients with asthma or chronic obstructive pulmonary disease." Pharmacotherapy 14 (1994): 729-33. [PMID: 7885977]
260	Ferguson GT, Funck-Brentano C, Fischer T, Darken P, Reisner C "Cardiovascular Safety of Salmeterol in COPD." Chest 123 (2003): 1817-24. [PMID: 12796155]
261	Gelmont DM, Balmes JR, Yee A "Hypokalemia induced by inhaled bronchodilators." Chest 94 (1988): 763-6. [PMID: 3168573]
262	Gross TL, Sokol RJ "Severe hypokalemia and acidosis: a potential complication of beta- adrenergic treatment." Am J Obstet Gynecol 138 (1980): 1225-6. [PMID: 7446635]
263	Hastwell G, Lambert BE "The effect of oral salbutamol on serum potassium and blood sugar." Br J Obstet Gynaecol 85 (1978): 767-9. [PMID: 708661]
264	Hurlbert BJ, Edelman JD, David K "Serum potassium levels during and after terbutaline." Anesth Analg 60 (1981): 723-5. [PMID: 7197475]
265	Hypokalaemia due to salbutamol overdosage. Br Med J (Clin Res Ed) 283 (1981): 500-1. [PMID: 6114774]
266	Kantola I, Tarssanen L "Hypokalemia from usual salbutamol dosage ." Chest 89 (1986): 619-20. [PMID: 3956296]
267	Lowe MD, Rowland E, Brown MJ, Grace AA "Beta(2) adrenergic receptors mediate important electrophysiological effects in human ventricular myocardium." Heart 86 (2001): 45-51. [PMID: 11410561]
268	Milic M, Bao X, Rizos D, Liu F, Ziegler MG "Literature review and pilot studies of the effect of qt correction formulas on reported beta(2)-agonist-induced QTc prolongation." Clin Ther 28 (2006): 582-90. [PMID: 16750469]
269	Product Information. Arcapta Neohaler (indacaterol). Novartis Pharmaceuticals, East Hanover, NJ.
270	Product Information. Breo Ellipta (fluticasone-vilanterol). GlaxoSmithKline, Research Triangle Park, NC.
271	Product Information. Brovana (arformoterol). Sepracor Inc, Marlborough, MA.
272	Product Information. Foradil (formoterol) Novartis Pharmaceuticals, East Hanover, NJ.
273	Product Information. Maxair (pirbuterol). 3M Pharmaceuticals, St. Paul, MN.
274	Product Information. Proventil (albuterol). Schering Laboratories, Kenilworth, NJ.
275	Product Information. Severent (salmeterol). Glaxo Wellcome, Research Triangle Park, NC.
276	Product Information. Striverdi Respimat (olodaterol). Boehringer Ingelheim, Ridgefield, CT.
277	Product Information. Xopenex (levalbuterol). Sepracor, Marlborough, MA.
278	Rakhmanina NY, Kearns GL, Farrar HC "Hypokalemia in an asthmatic child from abuse of albuterol metered dose inhaler." Pediatr Emerg Care 14 (1998): 145-7. [PMID: 9583400]
279	Sanders JP, Potter DE, Ellis S, Bee DE, Grant JA "Metabolic and cardiovascular effects of carbuterol and metaproterenol." J Allergy Clin Immunol 60 (1977): 174-9. [PMID: 19514]
280	Sun ZH, Swan H, Vitasalo M, Toivonen L "Effects of epinephrine and phenylephrine on QT interval dispersion in congenital long QT syndrome." J Am Coll Cardiol 31 (1998): 1400-5. [PMID: 9581741]
281	Tveskov C, Djurhuus MS, Klitgaard NAH, Egstrup K "Potassium and magnesium distribution, ECG changes, and ventricular ectopic beats during beta(2)-adrenergic stimulation with terbutaline in healthy subjects." Chest 106 (1994): 1654-9. [PMID: 7988180]
282	Whyte KF, Addis GJ, Whitesmith R, Reid JL "The mechanism of salbutamol-induced hypokalaemia." Br J Clin Pharmacol 23 (1987): 65-71. [PMID: 3545273]
283	Windom H, Grainger J, Burgess C, Crane J, Pearce N, Beasley R "A comparison of the haemodynamic and hypokalaemic effects of inhaled pirbuterol and salbutamol." N Z Med J 103 (1990): 259-61. [PMID: 1972557]
284	Wong CS, Pavord ID, Williams J, Britton JR, Tattersfield AE "Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma." Lancet 336 (1990): 1396-9. [PMID: 1978872]
285	Larsson S, Svedmyr N "Bronchodilating effect and side effects of beta2- adrenoceptor stimulants by different modes of administration (tablets, metered aerosol, and combinations thereof). A study with salbutamol inasthmatics." Am Rev Respir Dis 116 (1977): 861-9. [PMID: 921062]
286	Goodnick PJ, Jerry J, Parra F "Psychotropic drugs and the ECG: focus on the QTc interval." Expert Opin Pharmacother 3 (2002): 479-98. [PMID: 11996627]
287	Kane JM, Carson WH, Saha AR, et al. "Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder." J Clin Psychiatry 63 (2002): 763-71. [PMID: 12363115]
288	Keck PE Jr, Marcus R, Tourkodimitris S, et al. "A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania." Am J Psychiatry 160 (2003): 1651-8. [PMID: 12944341]
289	Nelson S, Leung JG "Torsades de Pointes After Administration of Low-Dose Aripiprazole (February)." Ann Pharmacother (2013):. [PMID: 23362038]
290	Pigott TA, Carson WH, Saha AR, Torbeyns AF, Stock EG, Ingenito GG "Aripiprazole for the prevention of relapse in stabilized patients with chronic schizophrenia: a placebo-controlled 26-week study." J Clin Psychiatry 64 (2003): 1048-56. [PMID: 14628980]
291	Product Information. Abilify (aripiprazole). Bristol-Myers Squibb, Princeton, NJ.
292	Product Information. Saphris (asenapine). Schering-Plough Corporation, Kenilworth, NJ.
293	Product Information. Colazal (balsalazide) Salix Pharmaceuticals, Palo Alto, CA.
294	Abbas R, Hug BA, Leister C, Sonnichsen D "A randomized, crossover, placebo- and moxifloxacin-controlled study to evaluate the effects of bosutinib (SKI-606), a dual Src/Abl tyrosine kinase inhibitor, on cardiac repolarization in healthy adult subjects." Int J Cancer 131 (2012): Epub. [PMID: 22065400]
295	Multum Information Services, Inc. Expert Review Panel.
296	Product Information. Sprycel (dasatinib). Bristol-Myers Squibb, Princeton, NJ.
297	Product Information. Austedo (deutetrabenazine). Teva Pharmaceuticals USA, North Wales, PA.
298	Product Information. Braftovi (encorafenib). Array BioPharma Inc., Boulder, CO.
299	Product Information. Rozlytrek (entrectinib). Genentech, South San Francisco, CA.
300	Product Information. Halaven (eribulin). Eisai Inc, Teaneck, NJ.
301	Product Information. Rukobia (fostemsavir). ViiV Healthcare, Research Triangle Park, NC.
302	Product Information. Xospata (gilteritinib). Astellas Pharma US, Inc, Deerfield, IL.
303	Kajiyama Y, Fujii K, Takeuchi H, Manabe Y "Ginkgo seed poisoning." Pediatrics 109 (2002): 325-7. [PMID: 11826216]
304	Granger AS "Ginkgo biloba precipitating epileptic seizures." Age Ageing 30 (2001): 523-5. [PMID: 11742783]
305	Miller LG "Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions." Arch Intern Med 158 (1998): 2200-11. [PMID: 9818800]
306	Spinella M "Herbal medicines and epilepsy: the potential for benefit and adverse effects." Epilepsy Behav 2 (2001): 524-32. [PMID: 12609386]
307	Gregory PJ "Seizure associated with Ginkgo biloba?." Ann Intern Med 134 (2001): 344. [PMID: 11182853]
308	Harms SL, Garrard J, Schwinghammer P, Eberly LE, Chang Y, Leppik IE "Ginkgo biloba use in nursing home elderly with epilepsy or seizure disorder." Epilepsia 47 (2006): 323-9. [PMID: 16499756]
309	Miwa H, Iijima M, Tanaka S, Mizuno Y "Generalized convulsions after consuming a large amount of Gingko nuts." Epilepsia 42 (2001): 280-1. [PMID: 11240603]
310	Kupiec T, Raj V "Fatal seizures due to potential herb-drug interactions with Ginkgo biloba." J Anal Toxicol 29 (2005): 755-8. [PMID: 16419414]
311	Product Information. Daurismo (glasdegib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
312	Product Information. Indium Oxyquinoline In-111 (indium oxyquinoline In-111). GE Healthcare, Princeton, NJ.
313	Product Information. Besponsa (inotuzumab ozogamicin). Wyeth Laboratories, Philadelphia, PA.
314	Product Information. Fosrenol (lanthanum carbonate). Shire US Inc, Florence, KY.
315	Product Information. Nuzyra (omadacycline). Paratek Pharmaceuticals, Inc., Boston, MA.
316	Product Information. Seysara (sarecycline). Allergan Inc, Irvine, CA.
317	Product Information. Lucemyra (lofexidine). US WorldMeds LLC, Louisville , KY.
318	Product Information. Kaletra (lopinavir-ritonavir) Abbott Pharmaceutical, Abbott Park, IL.
319	Product Information. CellCept (mycophenolate mofetil). Roche Laboratories, Nutley, NJ.
320	Product Information. Myfortic (mycophenolic acid). Novartis Pharmaceuticals, East Hanover, NJ.
321	Product Information. Isturisa (osilodrostat). Recordati Rare Diseases Inc, Lebanon, NJ.
322	Product Information. Nuplazid (pimavanserin). Accelis Pharma, East Windsor, NJ.
323	Salik JM, Kurtin P "Severe hyponatremia after colonoscopy preparation in a patient with the acquired immune deficiency syndrome." Am J Gastroenterol 80 (1985): 177-9. [PMID: 2983533]
324	Product Information. Seroquel (quetiapine). Zeneca Pharmaceuticals, Wilmington, DE.
325	Sala M, Vicentini A, Brambilla P, et al. "QT interval prolongation related to psychoactive drug treatment: a comparison of monotherapy versus polytherapy." Ann Gen Psychiatry 4 (2005): 1. [PMID: 15845138]
326	Vieweg WV "New generation antipsychotic drugs and QTc interval prolongation." Prim Care Companion J Clin Psychiatry 5 (2003): 205-15. [PMID: 15213787]
327	Vieweg WV, Schneider RK, Wood MA "Torsade de pointes in a patient with complex medical and psychiatric conditions receiving low-dose quetiapine." Acta Psychiatr Scand 112 (2005): 318-22. [PMID: 16156840]
328	Product Information. Ultane (sevoflurane). Abbott Pharmaceutical, Abbott Park, IL.
329	Product Information. Sutent (sunitinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
330	Product Information. Xenazine (tetrabenazine). Prestwick Pharmaceuticals Inc, Washington DC, VA.
331	Product Information. Thalomid (thalidomide). Celgene Corporation, Warren, NJ.
332	Product Information. Ingrezza (valbenazine). Neurocrine Biosciences, Inc., San Diego, CA.
333	Eggleston W, Clark KH, Marraffa JM "Loperamide abuse associated with cardiac dysrhythmia and death." Ann Emerg Med 69 (2017): 83-6. [PMID: 27140747]
334	US Food and Drug Administration "FDA warns about serious heart problems with high doses of the antidiarrheal medicine loperamide (Imodium), including from abuse and misuse.".
335	Product Information. Lariam (mefloquine). Roche Laboratories, Nutley, NJ.
336	Canadian Pharmacists Association "e-CPS."
337	Johnson EJ, MacGowan AP, Potter MN, et al "Reduced absorption of oral ciprofloxacin after chemotherapy for haematological malignancy." J Antimicrob Chemother 25 (1990): 837-42. [PMID: 2373666]
338	Nesher G, Mates M, Zevin S "Effect of caffeine consumption on efficacy of methotrexate in rheumatoid arthritis." Arthritis Rheum 48 (2003): 571-572. [PMID: 12571869]
339	Dalle JH, Auvrignon A, Vassal G, Leverger G "Interaction Between Methotrexate and Ciprofloxacin." J Pediatr Hematol Oncol 24 (2002): 321-322
340	Product Information. Nulibry (fosdenopterin). Origin Biosciences Inc, Boston, MA.
341	Product Information. Oxsoralen (methoxsalen). ICN Pharmaceuticals Inc, Costa Mesa, CA.
342	Product Information. Uvadex (methoxsalen). Therakos Inc, Exton, PA.
343	Product Information. Remeron (mirtazapine). Organon, West Orange, NJ.
344	Product Information. Zyprexa (olanzapine). Lilly, Eli and Company, Indianapolis, IN.
345	Product Information. Alimta (pemetrexed). Lilly, Eli and Company, Indianapolis, IN.
346	Product Information. Definity (perflutren). Lantheus Medical Imaging Inc, North Billerica, MA.
347	Product Information. Optison (perflutren). Mallinckrodt Medical Inc, St. Louis, MO.
348	Blakely KM, Drucker AM, Rosen CF "Drug-induced photosensitivity-an update: Culprit drugs, prevention and management." Drug Saf 42 (2019): 827-47. [PMID: 30888626]
349	Product Information. Photofrin (porfimer). Sanofi Winthrop Pharmaceuticals, New York, NY.
350	Hanci V, Aydin M, Yurtlu BS, et.al "Anesthesia induction with sevoflurane and propofol: evaluation of P-wave dispersion, QT and corrected QT intervals." Kaohsiung J Med Sci 26 (2010): 470-7. [PMID: 20837343]
351	Kim DH, Kweon TD, Nam SB, Han DW, Cho WY, Lee JS "Effects of target concentration infusion of propofol and tracheal intubation on QTc interval." Anaesthesia 63 (2008): 1061-4. [PMID: 18717665]
352	Kleinsasser A, Kuenszberg E, Loeckinger A, et.al "Sevoflurane, but not propofol, significantly prolongs the Q-T interval." Anesth Analg 90 (2000): 25-7. [PMID: 10624970]
353	Kleinsasser A, Loeckinger A, Lindner KH, Keller C, Boehler M, Puehringer F "Reversing sevoflurane-associated Q-Tc prolongation by changing to propofol." Anaesthesia 56 (2001): 248-50. [PMID: 11251432]
354	Paventi S, Santevecchi A, Ranieri R "Effects of sevoflurane versus propofol on QT interval." Minerva Anestesiol 67 (2001): 637-40. [PMID: 11731753]
355	Scalese MJ, Herring HR, Rathburn RC, Skrepnek GH, Ripley TL "Propofol-associated QTc prolongation." Ther Adv Drug Saf 7 (2016): 68-78. [PMID: 27298717]
356	Staikou C, Stamelos M, Stavroulakis E "Impact of anaesthetic drugs and adjuvants on ECG markers of torsadogenicity." Br J Anaesth 112 (2014): 217-30. [PMID: 24305646]
357	Toyoda T, Terao Y, Oji M, Okada M, Fukusaki M, Sumikawa K "The interaction of antiemetic dose of droperidol with propofol on QT interval during anesthetic induction." J Anesth 27 (2013): 885-9. [PMID: 23660990]
358	Whyte SD, Booker PD, Buckley DG "The Effects of Propofol and Sevoflurane on the QT Interval and Transmural Dispersion of Repolarization in Children." Anesth Analg 100 (2005): 71-77. [PMID: 15616054]
359	Wutzler A, De Asmundis C, Matsuda H, et.al "Effects of propofol on ventricular repolarization and incidence of malignant arrhythmias in adults." J Electrocardiol 51 (2018): 170-4. [PMID: 29174097]
360	European Medicines Agency "CHMP Assessment Report for Latixa. International nonproprietary name: ranolazine.".
361	Product Information. Ranexa (ranolazine). Calmoseptine Inc, Huntington Beach, CA.
362	Kays MB, Overholser BR, Mueller BA, Moe SM, Sowinski KM "Effects of sevelamer hydrochloride and calcium acetate on the oral bioavailability of ciprofloxacin." Am J Kidney Dis 42 (2003): 1253-9. [PMID: 14655198]
363	Product Information. Nexavar (sorafenib). Bayer Pharmaceutical Inc, West Haven, CT.
364	Product Information. Ketek (telithromycin). Aventis Pharmaceuticals, Bridgewater, NJ.
365	Antonelli D, Atar S, Freedberg NA, Rosenfeld T "Torsade de pointes in patients on chronic amiodarone treatment: contributing factors and drug interactions." Isr Med Assoc J 7 (2005): 163-5. [PMID: 15792261]
366	Dattilo PB, Nordin C "Prolonged QT associated with an overdose of trazodone." J Clin Psychiatry 68 (2007): 1309-10. [PMID: 17854263]
367	Levenson JL "Prolonged QT interval after trazodone overdose." Am J Psychiatry 156 (1999): 969-70. [PMID: 10360146]
368	Mazur A, Strasberg B, Kusniec J, Sclarovsky S "QT prolongation and polymorphous ventricular tachycardia associated with trasodone-amiodarone combination." Int J Cardiol 52 (1995): 27-9. [PMID: 8707432]
369	Product Information. Oleptro (traZODone). Labopharm Inc, Laval, AL.
370	Product Information. Visudyne (verteporfin) Valeant Pharmaceuticals, Costa Mesa, CA.
371	Sudoh T, Fujimura A, Shiga T, Sasaki M, Harada K, Tateishi T, Ohashi K, Ebihara A "Renal clearance of lomefloxacin is decreased by furosemide." Eur J Clin Pharmacol 46 (1994): 267-9. [PMID: 8070509]
372	Weidekamm E, Portmann R, Suter K, et al "Single- and multiple-dose pharmacokinetics of fleroxacin, a trifluorinated quinolone, in humans." Antimicrob Agents Chemother 31 (1987): 1909-14
373	Shimada J, Yamaji T, Ueda Y, Uchida H, Kusajma H, Irikura T "Mechanism of renal excretion of AM-715, a new quinolonecarboxylic acid derivative, in rabbits, dogs, and humans." Antimicrob Agents Chemother 23 (1983): 1-7
374	Crouch MA, Limon L, Cassano AT "Clinical relevance and management of drug-related QT interval prolongation." Pharmacotherapy 23 (2003): 881-908. [PMID: 12885102]
375	Kounas SP, Letsas KP, Sideris A, Efraimidis M, Kardaras F "QT interval prolongation and torsades de pointes due to a coadministration of metronidazole and amiodarone." Pacing Clin Electrophysiol 28 (2005): 472-3. [PMID: 15869686]
376	Product Information. Flagyl (metronidazole). Searle, Skokie, IL.
377	Product Information. Pylera (bismuth subcitrate potassium/metronidazo/TCN). Aptalis Pharma, Birmingham, AL.

Details of Drug

Details of Drug

Cite MecDDI

About MecDDI

Correspondence